<?xml version="1.0" encoding="utf-8"?>
<root>
  <!-- 
    Microsoft ResX Schema 
    
    Version 2.0
    
    The primary goals of this format is to allow a simple XML format 
    that is mostly human readable. The generation and parsing of the 
    various data types are done through the TypeConverter classes 
    associated with the data types.
    
    Example:
    
    ... ado.net/XML headers & schema ...
    <resheader name="resmimetype">text/microsoft-resx</resheader>
    <resheader name="version">2.0</resheader>
    <resheader name="reader">System.Resources.ResXResourceReader, System.Windows.Forms, ...</resheader>
    <resheader name="writer">System.Resources.ResXResourceWriter, System.Windows.Forms, ...</resheader>
    <data name="Name1"><value>this is my long string</value><comment>this is a comment</comment></data>
    <data name="Color1" type="System.Drawing.Color, System.Drawing">Blue</data>
    <data name="Bitmap1" mimetype="application/x-microsoft.net.object.binary.base64">
        <value>[base64 mime encoded serialized .NET Framework object]</value>
    </data>
    <data name="Icon1" type="System.Drawing.Icon, System.Drawing" mimetype="application/x-microsoft.net.object.bytearray.base64">
        <value>[base64 mime encoded string representing a byte array form of the .NET Framework object]</value>
        <comment>This is a comment</comment>
    </data>
                
    There are any number of "resheader" rows that contain simple 
    name/value pairs.
    
    Each data row contains a name, and value. The row also contains a 
    type or mimetype. Type corresponds to a .NET class that support 
    text/value conversion through the TypeConverter architecture. 
    Classes that don't support this are serialized and stored with the 
    mimetype set.
    
    The mimetype is used for serialized objects, and tells the 
    ResXResourceReader how to depersist the object. This is currently not 
    extensible. For a given mimetype the value must be set accordingly:
    
    Note - application/x-microsoft.net.object.binary.base64 is the format 
    that the ResXResourceWriter will generate, however the reader can 
    read any of the formats listed below.
    
    mimetype: application/x-microsoft.net.object.binary.base64
    value   : The object must be serialized with 
            : System.Runtime.Serialization.Formatters.Binary.BinaryFormatter
            : and then encoded with base64 encoding.
    
    mimetype: application/x-microsoft.net.object.soap.base64
    value   : The object must be serialized with 
            : System.Runtime.Serialization.Formatters.Soap.SoapFormatter
            : and then encoded with base64 encoding.

    mimetype: application/x-microsoft.net.object.bytearray.base64
    value   : The object must be serialized into a byte array 
            : using a System.ComponentModel.TypeConverter
            : and then encoded with base64 encoding.
    -->
  <xsd:schema id="root" xmlns="" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:msdata="urn:schemas-microsoft-com:xml-msdata">
    <xsd:import namespace="http://www.w3.org/XML/1998/namespace" />
    <xsd:element name="root" msdata:IsDataSet="true">
      <xsd:complexType>
        <xsd:choice maxOccurs="unbounded">
          <xsd:element name="metadata">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" />
              </xsd:sequence>
              <xsd:attribute name="name" use="required" type="xsd:string" />
              <xsd:attribute name="type" type="xsd:string" />
              <xsd:attribute name="mimetype" type="xsd:string" />
              <xsd:attribute ref="xml:space" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="assembly">
            <xsd:complexType>
              <xsd:attribute name="alias" type="xsd:string" />
              <xsd:attribute name="name" type="xsd:string" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="data">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" msdata:Ordinal="1" />
                <xsd:element name="comment" type="xsd:string" minOccurs="0" msdata:Ordinal="2" />
              </xsd:sequence>
              <xsd:attribute name="name" type="xsd:string" use="required" msdata:Ordinal="1" />
              <xsd:attribute name="type" type="xsd:string" msdata:Ordinal="3" />
              <xsd:attribute name="mimetype" type="xsd:string" msdata:Ordinal="4" />
              <xsd:attribute ref="xml:space" />
            </xsd:complexType>
          </xsd:element>
          <xsd:element name="resheader">
            <xsd:complexType>
              <xsd:sequence>
                <xsd:element name="value" type="xsd:string" minOccurs="0" msdata:Ordinal="1" />
              </xsd:sequence>
              <xsd:attribute name="name" type="xsd:string" use="required" />
            </xsd:complexType>
          </xsd:element>
        </xsd:choice>
      </xsd:complexType>
    </xsd:element>
  </xsd:schema>
  <resheader name="resmimetype">
    <value>text/microsoft-resx</value>
  </resheader>
  <resheader name="version">
    <value>2.0</value>
  </resheader>
  <resheader name="reader">
    <value>System.Resources.ResXResourceReader, System.Windows.Forms, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b77a5c561934e089</value>
  </resheader>
  <resheader name="writer">
    <value>System.Resources.ResXResourceWriter, System.Windows.Forms, Version=4.0.0.0, Culture=neutral, PublicKeyToken=b77a5c561934e089</value>
  </resheader>
  <data name="# Use in Indication, Posology and method and administration, contraindicated conditions, use in Special Population unapproved in the label" xml:space="preserve">
    <value># Use in Indication, Posology and method and administration, contraindicated conditions, use in Special Population unapproved in the label</value>
  </data>
  <data name="1 g probenecid" xml:space="preserve">
    <value>1 g probenecid</value>
  </data>
  <data name="2 g probenecid" xml:space="preserve">
    <value>2 g probenecid</value>
  </data>
  <data name="2 hours after end of cidofovir" xml:space="preserve">
    <value>2 hours after end of cidofovir</value>
  </data>
  <data name="3 hours before start of cidofovir" xml:space="preserve">
    <value>3 hours before start of cidofovir</value>
  </data>
  <data name="4 g probenecid" xml:space="preserve">
    <value>4 g probenecid</value>
  </data>
  <data name="8 hours after end of cidofovir" xml:space="preserve">
    <value>8 hours after end of cidofovir</value>
  </data>
  <data name="&lt;b&gt;If you are allergic&lt;/b&gt; to cidofovir or any of the other ingredients of this medicine (listed in section 6)." xml:space="preserve">
    <value>&lt;b&gt;If you are allergic&lt;/b&gt; to cidofovir or any of the other ingredients of this medicine (listed in section 6).</value>
  </data>
  <data name="&lt;b&gt;If you cannot take the medicine probenecid&lt;/b&gt; because of a serious allergy to probenecid or other sulfa-containing medicines (e.g. sulfamethoxazole)." xml:space="preserve">
    <value>&lt;b&gt;If you cannot take the medicine probenecid&lt;/b&gt; because of a serious allergy to probenecid or other sulfa-containing medicines (e.g. sulfamethoxazole).</value>
  </data>
  <data name="&lt;b&gt;If you have diabetes mellitus.&lt;/b&gt;Cidofovir should be used with caution in diabetic patients due to the potential increased risk of developing low pressure in the eye &lt;i&gt;(ocular hypotony)&lt;/i&gt;." xml:space="preserve">
    <value>&lt;b&gt;If you have diabetes mellitus.&lt;/b&gt;Cidofovir should be used with caution in diabetic patients due to the potential increased risk of developing low pressure in the eye &lt;i&gt;(ocular hypotony)&lt;/i&gt;.</value>
  </data>
  <data name="&lt;b&gt;If you have ever had kidney disease.&lt;/b&gt;" xml:space="preserve">
    <value>&lt;b&gt;If you have ever had kidney disease.&lt;/b&gt;</value>
  </data>
  <data name="&lt;b&gt;Induction treatment&lt;/b&gt; Dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) once weekly for two consecutive weeks." xml:space="preserve">
    <value>&lt;b&gt;Induction treatment&lt;/b&gt; Dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) once weekly for two consecutive weeks.</value>
  </data>
  <data name="&lt;b&gt;Kidney damage is the major side effect of cidofovir treatment.&lt;/b&gt; Therefore, your doctor may need to monitor carefully, particularly if you already have kidney problems or are on haemodialysis." xml:space="preserve">
    <value>&lt;b&gt;Kidney damage is the major side effect of cidofovir treatment.&lt;/b&gt; Therefore, your doctor may need to monitor carefully, particularly if you already have kidney problems or are on haemodialysis.</value>
  </data>
  <data name="&lt;b&gt;Maintenance treatment&lt;/b&gt; Beginning two weeks after the completion of induction treatment, the recommended maintenance dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) administered once every two weeks." xml:space="preserve">
    <value>&lt;b&gt;Maintenance treatment&lt;/b&gt; Beginning two weeks after the completion of induction treatment, the recommended maintenance dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) administered once every two weeks.</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Children&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Children&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Cidofovir 75 mg/ml concentrate for solution for infusion contains sodium&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Cidofovir 75 mg/ml concentrate for solution for infusion contains sodium&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Cidofovir with food and drink&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Cidofovir with food and drink&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Common side effects&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Common side effects&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Do not use cidofovir&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Do not use cidofovir&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Dose in adults&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Dose in adults&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Driving and using machines&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Driving and using machines&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; How IV fluids are given before cidofovir&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; How IV fluids are given before cidofovir&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; How to take probenecid with cidofovir&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; How to take probenecid with cidofovir&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; If you use more cidofovir than you should&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; If you use more cidofovir than you should&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Possible side effects of taking probenecid&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Possible side effects of taking probenecid&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Pregnancy and breast-feeding&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Pregnancy and breast-feeding&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Very common side effects&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Very common side effects&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Warnings and precautions&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; Warnings and precautions&lt;/p&gt;</value>
  </data>
  <data name="&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; What is CMV retinitis?&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p class='FaqTitle'&gt;&lt;i class='glyphicon glyphicon-hand-right'&gt;&lt;/i&gt; What is CMV retinitis?&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Cidofovir is used to treat an eye infection called CMV retinitis in patients with AIDS (Acquired Immunodeficiency Syndrome).&lt;/b&gt;  Cidofovir will not cure CMV retinitis but may improve your condition by delaying progression of the disease.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Cidofovir is used to treat an eye infection called CMV retinitis in patients with AIDS (Acquired Immunodeficiency Syndrome).&lt;/b&gt;  Cidofovir will not cure CMV retinitis but may improve your condition by delaying progression of the disease.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Common side effects possibly related to probenecid&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Common side effects possibly related to probenecid&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;During treatment with cidofovir you should receive regular follow-up eye examinations&lt;/b&gt; for possible eye irritation, inflammation or swelling. &lt;b&gt;If you get pain, redness or itching of the eye or changes in your vision, tell your doctor promptly.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;During treatment with cidofovir you should receive regular follow-up eye examinations&lt;/b&gt; for possible eye irritation, inflammation or swelling. &lt;b&gt;If you get pain, redness or itching of the eye or changes in your vision, tell your doctor promptly.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Food should be taken&lt;/b&gt; before you are given cidofovir. Your doctor may instruct you to drink plenty of fluids before receiving cidofovir.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Food should be taken&lt;/b&gt; before you are given cidofovir. Your doctor may instruct you to drink plenty of fluids before receiving cidofovir.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;In general, women with HIV should not breast-feed&lt;/b&gt; in order to avoid passing HIV to their infant through the milk.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;In general, women with HIV should not breast-feed&lt;/b&gt; in order to avoid passing HIV to their infant through the milk.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;It is very important to tell your doctor if you are receiving other medicines that may damage your kidneys.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;It is very important to tell your doctor if you are receiving other medicines that may damage your kidneys.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Normal saline is given to lower the risk of kidney damage.&lt;/b&gt; You should receive a total of one litre of 0.9% (normal) saline solution intravenously (as a drip into a vein) before each cidofovir dose. The saline solution should be infused over a 1 hour period immediately before the cidofovir. If you can tolerate the additional fluid load, your doctor may administer a second litre of fluid. If administered, the second litre of saline should be given either at the start of the cidofovir or immediately afterwards, and infused over a 1 to 3 hour period. Your doctor may also tell you to drink plenty of fluids.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Normal saline is given to lower the risk of kidney damage.&lt;/b&gt; You should receive a total of one litre of 0.9% (normal) saline solution intravenously (as a drip into a vein) before each cidofovir dose. The saline solution should be infused over a 1 hour period immediately before the cidofovir. If you can tolerate the additional fluid load, your doctor may administer a second litre of fluid. If administered, the second litre of saline should be given either at the start of the cidofovir or immediately afterwards, and infused over a 1 to 3 hour period. Your doctor may also tell you to drink plenty of fluids.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines,&lt;/b&gt; including medicines obtained without a prescription, as these may interact with cidofovir or probenecid.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines,&lt;/b&gt; including medicines obtained without a prescription, as these may interact with cidofovir or probenecid.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;To lower the risk of kidney damage, probenecid tablets and intravenous fluids (saline solution) must be given on the day of each cidofovir&lt;/b&gt; (See sub-sections “How to take probenecid with cidofovir” and “How IV fluids are given before cidofovir” below.)&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;To lower the risk of kidney damage, probenecid tablets and intravenous fluids (saline solution) must be given on the day of each cidofovir&lt;/b&gt; (See sub-sections “How to take probenecid with cidofovir” and “How IV fluids are given before cidofovir” below.)&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;Very common side effects possibly related to probenecid&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;Very common side effects possibly related to probenecid&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;You should not be given cidofovir if you are breast-feeding.&lt;/b&gt; It is not known whether cidofovir is passed on to the baby in human milk. Because many medicines are passed through to human milk, nursing mothers should stop cidofovir or stop breast-feeding if they continue to receive cidofovir.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;You should not be given cidofovir if you are breast-feeding.&lt;/b&gt; It is not known whether cidofovir is passed on to the baby in human milk. Because many medicines are passed through to human milk, nursing mothers should stop cidofovir or stop breast-feeding if they continue to receive cidofovir.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;b&gt;You should not be given cidofovir if you are pregnant.&lt;/b&gt; If you become pregnant while receiving this medication, you must inform your doctor immediately. Cidofovir has been shown to cause damage in unborn animals and should not be used during pregnancy unless the potential benefits justify the risks to the foetus. &lt;b&gt;If you could get pregnant, you must use an effective method of contraception&lt;/b&gt; to stop you getting pregnant during treatment with cidofovir and for 1 month afterwards.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;b&gt;You should not be given cidofovir if you are pregnant.&lt;/b&gt; If you become pregnant while receiving this medication, you must inform your doctor immediately. Cidofovir has been shown to cause damage in unborn animals and should not be used during pregnancy unless the potential benefits justify the risks to the foetus. &lt;b&gt;If you could get pregnant, you must use an effective method of contraception&lt;/b&gt; to stop you getting pregnant during treatment with cidofovir and for 1 month afterwards.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;i&gt;(These can affect 1 to 10 users in 100)&lt;/i&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;i&gt;(These can affect 1 to 10 users in 100)&lt;/i&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;i&gt;(These can affect more than 1 user in 10)&lt;/i&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;i&gt;(These can affect more than 1 user in 10)&lt;/i&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;i&gt;&lt;b&gt;Dose adjustment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;i&gt;&lt;b&gt;Dose adjustment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;i&gt;&lt;b&gt;Maintenance treatment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;i&gt;&lt;b&gt;Maintenance treatment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;&lt;i&gt;&lt;b&gt;Starting (induction) treatment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;&lt;i&gt;&lt;b&gt;Starting (induction) treatment&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Additional reactions reported from post-marketing experience include kidney failure, damage to kidney tubule cells, inflammation of the pancreas and hearing impairment.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Additional reactions reported from post-marketing experience include kidney failure, damage to kidney tubule cells, inflammation of the pancreas and hearing impairment.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Any pain, redness or itching of the eye or changes in your vision should be promptly reported to your doctor so that your treatment can be reviewed.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Any pain, redness or itching of the eye or changes in your vision should be promptly reported to your doctor so that your treatment can be reviewed.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Beginning two weeks after completion of induction treatment, the recommended maintenance dose of cidofovir in patients with normal kidney function is 5 mg per kg of body weight given once every two weeks.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Beginning two weeks after completion of induction treatment, the recommended maintenance dose of cidofovir in patients with normal kidney function is 5 mg per kg of body weight given once every two weeks.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir 75 mg/ml concentrate for solution for infusion &lt;b&gt;is given by intravenous infusion (a drip into a vein)&lt;/b&gt;. It must &lt;b&gt;not&lt;/b&gt; be administered by other methods including intraocular injection (direct injection into the eye) or topically (on the skin). Cidofovir must be given by a doctor or nurse with appropriate experience in treating people with AIDS. The doctor or nurse will transfer the appropriate dose of cidofovir from the vial to an infusion bag containing 100 ml 0.9% (normal) saline solution. The entire volume of the bag will be infused into your vein at a constant rate over a period of 1 hour using a standard infusion pump. The recommended dose, frequency of use, or rate of infusion must not be exceeded. At the end of this leaflet, there is further information for healthcare professionals on how to administer cidofovir.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir 75 mg/ml concentrate for solution for infusion &lt;b&gt;is given by intravenous infusion (a drip into a vein)&lt;/b&gt;. It must &lt;b&gt;not&lt;/b&gt; be administered by other methods including intraocular injection (direct injection into the eye) or topically (on the skin). Cidofovir must be given by a doctor or nurse with appropriate experience in treating people with AIDS. The doctor or nurse will transfer the appropriate dose of cidofovir from the vial to an infusion bag containing 100 ml 0.9% (normal) saline solution. The entire volume of the bag will be infused into your vein at a constant rate over a period of 1 hour using a standard infusion pump. The recommended dose, frequency of use, or rate of infusion must not be exceeded. At the end of this leaflet, there is further information for healthcare professionals on how to administer cidofovir.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir caused reduced testes weight and low sperm count (hypospermia) in animals. Although not observed in human studies of cidofovir, such changes may occur in humans and cause infertility. &lt;b&gt;Men should practice barrier birth control methods during and for 3 months after treatment with cidofovir.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir caused reduced testes weight and low sperm count (hypospermia) in animals. Although not observed in human studies of cidofovir, such changes may occur in humans and cause infertility. &lt;b&gt;Men should practice barrier birth control methods during and for 3 months after treatment with cidofovir.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir has not been studied in children. Therefore, &lt;b&gt;this medicine should not be used in children.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir has not been studied in children. Therefore, &lt;b&gt;this medicine should not be used in children.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir is an antiviral medicine which blocks the replication of CMV by interfering with viral DNA production.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir is an antiviral medicine which blocks the replication of CMV by interfering with viral DNA production.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir is not used for the treatment of HIV infection. Cidofovir will not stop you passing HIV infection onto other people so &lt;b&gt;you should continue to take precautions to avoid infecting others.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir is not used for the treatment of HIV infection. Cidofovir will not stop you passing HIV infection onto other people so &lt;b&gt;you should continue to take precautions to avoid infecting others.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir may cause short-term side effects such as fatigue or weakness. If you drive or operate machinery, discuss this with your doctor to get advice about stopping these activities based upon your disease and your tolerance of the medicine.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir may cause short-term side effects such as fatigue or weakness. If you drive or operate machinery, discuss this with your doctor to get advice about stopping these activities based upon your disease and your tolerance of the medicine.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Cidofovir must be administered by a healthcare professional (doctor or nurse) in a hospital setting.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Cidofovir must be administered by a healthcare professional (doctor or nurse) in a hospital setting.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;CMV retinitis is an eye infection caused by a virus named cytomegalovirus (CMV). CMV attacks the retina of the eye and may cause loss of vision, and eventually lead to blindness. Patients with AIDS are at high risk of developing CMV retinitis or other forms of CMV disease such as colitis (an inflammatory bowel disease). Treatment for CMV retinitis is necessary to reduce the potential for blindness.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;CMV retinitis is an eye infection caused by a virus named cytomegalovirus (CMV). CMV attacks the retina of the eye and may cause loss of vision, and eventually lead to blindness. Patients with AIDS are at high risk of developing CMV retinitis or other forms of CMV disease such as colitis (an inflammatory bowel disease). Treatment for CMV retinitis is necessary to reduce the potential for blindness.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;For any further information on how your data may be stored or used, please &lt;a href='https://www.cidofovir.com/Home/ContactUs'&gt;contact us&lt;/a&gt; and we will be happy to provide you further information.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;For any further information on how your data may be stored or used, please &lt;a href='https://www.cidofovir.com/Home/ContactUs'&gt;contact us&lt;/a&gt; and we will be happy to provide you further information.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;For further information please do not hesitate to &lt;a href='https://www.cidofovir.com/Home/ContactUs'&gt;&lt;b&gt;contact us&lt;/b&gt;&lt;/a&gt;  or speak to your &lt;b&gt;doctor&lt;/b&gt;.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;For further information please do not hesitate to &lt;a href='https://www.cidofovir.com/Home/ContactUs'&gt;&lt;b&gt;contact us&lt;/b&gt;&lt;/a&gt;  or speak to your &lt;b&gt;doctor&lt;/b&gt;.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;headache, weakness/fatigue, chills and allergic reactions.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;headache, weakness/fatigue, chills and allergic reactions.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;If any of these apply to you, talk to your doctor. &lt;b&gt;You are not to be given cidofovir.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;If any of these apply to you, talk to your doctor. &lt;b&gt;You are not to be given cidofovir.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;If you have accidentally been given more cidofovir than prescribed for you, tell your doctor immediately.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;If you have accidentally been given more cidofovir than prescribed for you, tell your doctor immediately.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;If you have kidney problems, cidofovir may not be appropriate treatment for you. Samples of your urine and/or blood will be taken before each infusion of cidofovir and used for testing kidney function. For patients with evidence of decreased kidney function, your cidofovir dose may be interrupted or stopped depending on your individual case.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;If you have kidney problems, cidofovir may not be appropriate treatment for you. Samples of your urine and/or blood will be taken before each infusion of cidofovir and used for testing kidney function. For patients with evidence of decreased kidney function, your cidofovir dose may be interrupted or stopped depending on your individual case.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Inflammation of the eye, reduced pressure in the eyes, difficult or laboured breathing, shortness of breath, diarrhoea and chills.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Inflammation of the eye, reduced pressure in the eyes, difficult or laboured breathing, shortness of breath, diarrhoea and chills.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Like all medicines, this medicine can cause side effects, although not everybody gets them.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Like all medicines, this medicine can cause side effects, although not everybody gets them.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;low white blood cell counts, headache, nausea, vomiting, protein in the urine, increase in blood creatinine (a measure of kidney function), hair loss, rash, weakness/fatigue and fever.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;low white blood cell counts, headache, nausea, vomiting, protein in the urine, increase in blood creatinine (a measure of kidney function), hair loss, rash, weakness/fatigue and fever.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;nausea, vomiting, rash and fever.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;nausea, vomiting, rash and fever.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;PASSs can either be &lt;b&gt;clinical trials&lt;/b&gt; or &lt;b&gt;non-interventional studies&lt;/b&gt;.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;PASSs can either be &lt;b&gt;clinical trials&lt;/b&gt; or &lt;b&gt;non-interventional studies&lt;/b&gt;.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Probenecid is only taken on the same day that cidofovir is given.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Probenecid is only taken on the same day that cidofovir is given.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Probenecid may also cause other side effects including loss of appetite, sore gums, flushing, hair loss, dizziness, reduced red blood cell count and increased frequency of passing water (urinating). Allergic reactions, with skin inflammation, itching, hives and, rarely, severe allergic reactions, and serious skin reaction have occurred. There have been reports of reduced white blood counts, liver toxicity, kidney toxicity and destruction of red blood cells. Reductions in blood cell and platelet counts have also occurred.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Probenecid may also cause other side effects including loss of appetite, sore gums, flushing, hair loss, dizziness, reduced red blood cell count and increased frequency of passing water (urinating). Allergic reactions, with skin inflammation, itching, hives and, rarely, severe allergic reactions, and serious skin reaction have occurred. There have been reports of reduced white blood counts, liver toxicity, kidney toxicity and destruction of red blood cells. Reductions in blood cell and platelet counts have also occurred.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Probenecid may interact with other medicines commonly used in the treatment of AIDS and AIDS-related illnesses, such as zidovudine (AZT). If you are taking zidovudine, you should discuss with your doctor whether to temporarily stop taking zidovudine or decrease the dose of zidovudine by 50% on days when cidofovir and probenecid are given.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Probenecid may interact with other medicines commonly used in the treatment of AIDS and AIDS-related illnesses, such as zidovudine (AZT). If you are taking zidovudine, you should discuss with your doctor whether to temporarily stop taking zidovudine or decrease the dose of zidovudine by 50% on days when cidofovir and probenecid are given.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Probenecid tablets are given to lower the risk of kidney damage. You must take 3 doses of probenecid tablets orally on the same day as cidofovir as shown in the following table:&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Probenecid tablets are given to lower the risk of kidney damage. You must take 3 doses of probenecid tablets orally on the same day as cidofovir as shown in the following table:&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Should you be interested in participating in the Cidofovir Exposure Registry, please visit the website &lt;a href='https://www.cidofovir.com' target='_blank'&gt;www.cidofovir.com&lt;/a&gt;.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Should you be interested in participating in the Cidofovir Exposure Registry, please visit the website &lt;a href='https://www.cidofovir.com' target='_blank'&gt;www.cidofovir.com&lt;/a&gt;.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Talk to your doctor or pharmacist or nurse before using cidofovir.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Talk to your doctor or pharmacist or nurse before using cidofovir.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The dose you will need is calculated based on your body weight.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The dose you will need is calculated based on your body weight.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The European medicinces agency has requested Tillomed to implement a non-interventional PASS Study for the additional monitoring of Cidofovir through an exposure registry the United Kingdom, Germany, Belgium and Spain&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The European medicinces agency has requested Tillomed to implement a non-interventional PASS Study for the additional monitoring of Cidofovir through an exposure registry the United Kingdom, Germany, Belgium and Spain&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The most common side effect observed with cidofovir is damage to the kidneys.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The most common side effect observed with cidofovir is damage to the kidneys.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The objectives of the study are:&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The objectives of the study are:&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The potential for interactions between cidofovir and anti-HIV protease inhibitors has not been studied.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The potential for interactions between cidofovir and anti-HIV protease inhibitors has not been studied.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The purpose of the information in PASS’s is to evaluate the safety and benefit-risk profile of a medicine and support regulatory decision-making. They aim to:&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The purpose of the information in PASS’s is to evaluate the safety and benefit-risk profile of a medicine and support regulatory decision-making. They aim to:&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The recommended dose of cidofovir in patients with normal kidney function is 5 mg per kg of body weight given once weekly for two consecutive weeks.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The recommended dose of cidofovir in patients with normal kidney function is 5 mg per kg of body weight given once weekly for two consecutive weeks.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;The safety and efficacy of cidofovir has not been demonstrated in diseases other than CMV retinitis in patients with AIDS.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;The safety and efficacy of cidofovir has not been demonstrated in diseases other than CMV retinitis in patients with AIDS.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Therefore, before giving you probenecid your doctor should consult the current prescribing information regarding the safety of probenecid. &lt;b&gt;You should also read the probenecid package leaflet.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Therefore, before giving you probenecid your doctor should consult the current prescribing information regarding the safety of probenecid. &lt;b&gt;You should also read the probenecid package leaflet.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;These include:&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;These include:&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;These medicines must be stopped &lt;b&gt;at least 7 days&lt;/b&gt; before taking cidofovir.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;These medicines must be stopped &lt;b&gt;at least 7 days&lt;/b&gt; before taking cidofovir.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;These side effects usually disappear when treatment with cidofovir is stopped. &lt;b&gt;If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist immediately.&lt;/b&gt;&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;These side effects usually disappear when treatment with cidofovir is stopped. &lt;b&gt;If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist immediately.&lt;/b&gt;&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;This medicine contains 2.5 mmol (or 57 mg) sodium per vial which should be taken into consideration if you are on a controlled sodium diet.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;This medicine contains 2.5 mmol (or 57 mg) sodium per vial which should be taken into consideration if you are on a controlled sodium diet.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;This study will allow identification of new safety information pertaining to cidofovir usage.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;This study will allow identification of new safety information pertaining to cidofovir usage.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;Tillomed are conducting a non-interventional Post Authorisation Safety Study for the safety of Cidofovir through a patient registry in the United Kingdom, Germany, Belgium and Spain.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;Tillomed are conducting a non-interventional Post Authorisation Safety Study for the safety of Cidofovir through a patient registry in the United Kingdom, Germany, Belgium and Spain.&lt;/p&gt;</value>
  </data>
  <data name="&lt;p&gt;To reduce the risk of nausea and/or vomiting associated with taking probenecid, you should eat food before each dose. Your doctor might instruct you to take other medicines such as anti-emetics (anti sickness medicines), antihistamines and/or paracetamol to decrease the side effects of probenecid.&lt;/p&gt;" xml:space="preserve">
    <value>&lt;p&gt;To reduce the risk of nausea and/or vomiting associated with taking probenecid, you should eat food before each dose. Your doctor might instruct you to take other medicines such as anti-emetics (anti sickness medicines), antihistamines and/or paracetamol to decrease the side effects of probenecid.&lt;/p&gt;</value>
  </data>
  <data name="Aamphotericin B (for fungal infection)" xml:space="preserve">
    <value>Aamphotericin B (for fungal infection)</value>
  </data>
  <data name="Abnormal parameters, if any" xml:space="preserve">
    <value>Abnormal parameters, if any</value>
  </data>
  <data name="About" xml:space="preserve">
    <value>About</value>
  </data>
  <data name="About Us" xml:space="preserve">
    <value>About Us</value>
  </data>
  <data name="Accept" xml:space="preserve">
    <value>Accept</value>
  </data>
  <data name="Accept Patient" xml:space="preserve">
    <value>Accept Patient</value>
  </data>
  <data name="Access and obtain a copy of your data on request; require the organisation to change incorrect or incomplete data;" xml:space="preserve">
    <value>Access and obtain a copy of your data on request; require the organisation to change incorrect or incomplete data;</value>
  </data>
  <data name="Access denied" xml:space="preserve">
    <value>Access denied</value>
  </data>
  <data name="Action" xml:space="preserve">
    <value>Action</value>
  </data>
  <data name="Activate" xml:space="preserve">
    <value>Activate</value>
  </data>
  <data name="Add Follow Up Form" xml:space="preserve">
    <value>Add Follow Up Form</value>
  </data>
  <data name="Add More" xml:space="preserve">
    <value>Add More</value>
  </data>
  <data name="Add Patient" xml:space="preserve">
    <value>Add Patient</value>
  </data>
  <data name="Add Prescriber" xml:space="preserve">
    <value>Add Prescriber</value>
  </data>
  <data name="Adefovir (for HBV infection)" xml:space="preserve">
    <value>Adefovir (for HBV infection)</value>
  </data>
  <data name="Adresse de contact" xml:space="preserve">
    <value>Adresse de contact</value>
  </data>
  <data name="Adverse Events" xml:space="preserve">
    <value>Adverse Events</value>
  </data>
  <data name="AE details" xml:space="preserve">
    <value>AE details</value>
  </data>
  <data name="All Patient" xml:space="preserve">
    <value>All Patient</value>
  </data>
  <data name="answer" xml:space="preserve">
    <value>answer</value>
  </data>
  <data name="Approve" xml:space="preserve">
    <value>Approve</value>
  </data>
  <data name="Approved" xml:space="preserve">
    <value>Approved</value>
  </data>
  <data name="Approved Indication" xml:space="preserve">
    <value>Approved Indication</value>
  </data>
  <data name="Are you sure?" xml:space="preserve">
    <value>Are you sure?</value>
  </data>
  <data name="As a data subject, you have a number of rights. You can:" xml:space="preserve">
    <value>As a data subject, you have a number of rights. You can:</value>
  </data>
  <data name="Automated decision-making." xml:space="preserve">
    <value>Automated decision-making.</value>
  </data>
  <data name="Back to Login" xml:space="preserve">
    <value>Back to Login</value>
  </data>
  <data name="Baseline Data Form" xml:space="preserve">
    <value>Baseline Data Form</value>
  </data>
  <data name="Baseline Form" xml:space="preserve">
    <value>Baseline Form</value>
  </data>
  <data name="Baseline Form View" xml:space="preserve">
    <value>Baseline Form View</value>
  </data>
  <data name="Baseline investigations" xml:space="preserve">
    <value>Baseline investigations</value>
  </data>
  <data name="Bicarbonate" xml:space="preserve">
    <value>Bicarbonate</value>
  </data>
  <data name="Biochemistry" xml:space="preserve">
    <value>Biochemistry</value>
  </data>
  <data name="BLH1" xml:space="preserve">
    <value>INFORMED CONSENT AND ELIGIBILITY</value>
  </data>
  <data name="BLH2" xml:space="preserve">
    <value>DEMOGRAPHIC DATA</value>
  </data>
  <data name="BLH3" xml:space="preserve">
    <value>TREATMENT INIT DETAILS</value>
  </data>
  <data name="BLH4" xml:space="preserve">
    <value>PRESCRIBER’S SIGN OFF</value>
  </data>
  <data name="BS1" xml:space="preserve">
    <value>INFORMED CONSENT</value>
  </data>
  <data name="BS2" xml:space="preserve">
    <value>INCLUSION CRITERIA</value>
  </data>
  <data name="BS3" xml:space="preserve">
    <value>DEMOGRAPHIC DATA</value>
  </data>
  <data name="BS4" xml:space="preserve">
    <value>MEDICAL HISTORY</value>
  </data>
  <data name="BS5" xml:space="preserve">
    <value>CONCOMITANT MEDICATIONS</value>
  </data>
  <data name="BS6" xml:space="preserve">
    <value>LABORATORY INVESTIGATIONS</value>
  </data>
  <data name="BS7" xml:space="preserve">
    <value>CIDOFOVIR TREATMENT INITIATION DETAILS</value>
  </data>
  <data name="BS8" xml:space="preserve">
    <value>PRESCRIBER’S SIGN OFF</value>
  </data>
  <data name="BST1" xml:space="preserve">
    <value>Informed Consent Given</value>
  </data>
  <data name="BST10" xml:space="preserve">
    <value>Treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction. It should be used only when other medicinal products are considered unsuitable.</value>
  </data>
  <data name="BST11" xml:space="preserve">
    <value>Other Indication, please specify:(Off-label)</value>
  </data>
  <data name="BST12" xml:space="preserve">
    <value>Contraindications</value>
  </data>
  <data name="BST13" xml:space="preserve">
    <value>Hypersensitivity to the Cidofovir or to any of the excipients (Sodium hydroxide and hydrochloric acid)</value>
  </data>
  <data name="BST14" xml:space="preserve">
    <value>Patients unable to receive probenecid or other sulfa containing medication</value>
  </data>
  <data name="BST15" xml:space="preserve">
    <value>Patients with renal insufficiency</value>
  </data>
  <data name="BST16" xml:space="preserve">
    <value>Concomitant administration of cidofovir and other potentially nephrotoxic agents</value>
  </data>
  <data name="BST17" xml:space="preserve">
    <value>Direct intraocular injection</value>
  </data>
  <data name="BST18" xml:space="preserve">
    <value>Posology and Method of administration</value>
  </data>
  <data name="BST19" xml:space="preserve">
    <value>Induction treatment Dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) once weekly for two consecutive weeks.</value>
  </data>
  <data name="BST2" xml:space="preserve">
    <value>Date participant/patient proxy signed written consent form</value>
  </data>
  <data name="BST20" xml:space="preserve">
    <value>Maintenance treatment Beginning two weeks after the completion of induction treatment, the recommended maintenance dose of cidofovir is 5 mg/kg body weight intravenous infusion at a constant rate over 1 hour) administered once every two weeks.</value>
  </data>
  <data name="BST21" xml:space="preserve">
    <value>Use in Special Populations</value>
  </data>
  <data name="BST22" xml:space="preserve">
    <value>Pediatric population (&lt; 18 years of age)</value>
  </data>
  <data name="BST23" xml:space="preserve">
    <value>Elderly population (&gt; 60 years of age)</value>
  </data>
  <data name="BST24" xml:space="preserve">
    <value>Pregnant and Lactating Females, Females of child-bearing potential not using contraception</value>
  </data>
  <data name="BST25" xml:space="preserve">
    <value>In case the country of the patient is Germany no further data collection should take place thereafter. No further data should be collected on patients treated off-label# within the registry to comply with German Law.</value>
  </data>
  <data name="BST26" xml:space="preserve">
    <value># Use in Indication, Posology and method and administration, contraindicated conditions, use in Special Population unapproved in the label</value>
  </data>
  <data name="BST27" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="BST28" xml:space="preserve">
    <value>Date of Birth</value>
  </data>
  <data name="BST29" xml:space="preserve">
    <value>Sex</value>
  </data>
  <data name="BST3" xml:space="preserve">
    <value>Country</value>
  </data>
  <data name="BST30" xml:space="preserve">
    <value>Did the patient have had any relevant Medical History?</value>
  </data>
  <data name="BST31" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="BST32" xml:space="preserve">
    <value>Please specify any significant/major illness, medical conditions or surgery in the past or at present.</value>
  </data>
  <data name="BST33" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="BST34" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="BST35" xml:space="preserve">
    <value>Or tick if Ongoing?</value>
  </data>
  <data name="BST36" xml:space="preserve">
    <value>Is the patient taking any concomitant medications at screening?</value>
  </data>
  <data name="BST37" xml:space="preserve">
    <value>Medications</value>
  </data>
  <data name="BST38" xml:space="preserve">
    <value>Medication</value>
  </data>
  <data name="BST39" xml:space="preserve">
    <value>Indication</value>
  </data>
  <data name="BST4" xml:space="preserve">
    <value>The following criteria MUST be answered YES for participant to be included in the study. In case any of the criterion is NO, the patient will not be eligible to participate in the study</value>
  </data>
  <data name="BST40" xml:space="preserve">
    <value>Dosage and units</value>
  </data>
  <data name="BST41" xml:space="preserve">
    <value>Frequency</value>
  </data>
  <data name="BST42" xml:space="preserve">
    <value>Route</value>
  </data>
  <data name="BST43" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="BST44" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="BST45" xml:space="preserve">
    <value>Or tick if on going at Screening Visit</value>
  </data>
  <data name="BST46" xml:space="preserve">
    <value>Specification</value>
  </data>
  <data name="BST47" xml:space="preserve">
    <value>Abnormal parameters, if any</value>
  </data>
  <data name="BST48" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="BST49" xml:space="preserve">
    <value>Haematology</value>
  </data>
  <data name="BST5" xml:space="preserve">
    <value>Is the patient exposed to Emcure’s Cidofovir 75mg/mlconcentrate for solution for infusion?</value>
  </data>
  <data name="BST50" xml:space="preserve">
    <value>Biochemistry</value>
  </data>
  <data name="BST51" xml:space="preserve">
    <value>Urea</value>
  </data>
  <data name="BST52" xml:space="preserve">
    <value>Creatinine</value>
  </data>
  <data name="BST53" xml:space="preserve">
    <value>Phosphate</value>
  </data>
  <data name="BST54" xml:space="preserve">
    <value>Uric acid</value>
  </data>
  <data name="BST55" xml:space="preserve">
    <value>Bicarbonate</value>
  </data>
  <data name="BST56" xml:space="preserve">
    <value>Urine analysis (including glycosuria)</value>
  </data>
  <data name="BST57" xml:space="preserve">
    <value>Serology</value>
  </data>
  <data name="BST58" xml:space="preserve">
    <value>Others (Specify)</value>
  </data>
  <data name="BST59" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="BST6" xml:space="preserve">
    <value>Is the patient or patient proxy (in event the patient is unable to consent) willing to provide written informedconsent?</value>
  </data>
  <data name="BST60" xml:space="preserve">
    <value>Please provide the following details regarding the intended treatment regimen</value>
  </data>
  <data name="BST61" xml:space="preserve">
    <value>Indication</value>
  </data>
  <data name="BST62" xml:space="preserve">
    <value>Dose (including units)</value>
  </data>
  <data name="BST63" xml:space="preserve">
    <value>Frequency of administration</value>
  </data>
  <data name="BST64" xml:space="preserve">
    <value>Route of administration (IV, Intraocular, Topical, etc.)</value>
  </data>
  <data name="BST65" xml:space="preserve">
    <value>Remarks</value>
  </data>
  <data name="BST66" xml:space="preserve">
    <value>Prescriber’s Statement</value>
  </data>
  <data name="BST67" xml:space="preserve">
    <value>I have reviewed this Baseline Data Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient.</value>
  </data>
  <data name="BST68" xml:space="preserve">
    <value>Prescriber’s Name</value>
  </data>
  <data name="BST69" xml:space="preserve">
    <value>Prescribers Email Id</value>
  </data>
  <data name="BST7" xml:space="preserve">
    <value>Criteria for classifying as ‘Off-label Use’</value>
  </data>
  <data name="BST70" xml:space="preserve">
    <value>Registration Number</value>
  </data>
  <data name="BST71" xml:space="preserve">
    <value>Telephone Number</value>
  </data>
  <data name="BST72" xml:space="preserve">
    <value>Hospital Address</value>
  </data>
  <data name="BST73" xml:space="preserve">
    <value>Contact Address</value>
  </data>
  <data name="BST74" xml:space="preserve">
    <value>Date of Acceptance</value>
  </data>
  <data name="BST8" xml:space="preserve">
    <value>Is the patient exposed to Emcure’s Cidofovir 75mg/ml concentrate for solution for infusion under any of the following conditions</value>
  </data>
  <data name="BST9" xml:space="preserve">
    <value>Approved Indication</value>
  </data>
  <data name="Cancel" xml:space="preserve">
    <value>Cancel</value>
  </data>
  <data name="Changer le mot de passe" xml:space="preserve">
    <value>Changer le mot de passe</value>
  </data>
  <data name="Cidofovir Administration" xml:space="preserve">
    <value>Cidofovir Administration</value>
  </data>
  <data name="Cidofovir Exposure Registry Information" xml:space="preserve">
    <value>Cidofovir Exposure Registry Information</value>
  </data>
  <data name="Cidofovir Exposure Registry of Emcure Pharma UK Ltd." xml:space="preserve">
    <value>Cidofovir Exposure Registry of Emcure Pharma UK Ltd.</value>
  </data>
  <data name="CIDOFOVIR TREATMENT INITIATION DETAILS" xml:space="preserve">
    <value>CIDOFOVIR TREATMENT INITIATION DETAILS</value>
  </data>
  <data name="Close" xml:space="preserve">
    <value>Close</value>
  </data>
  <data name="Comments" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="Con-comitant Medication given" xml:space="preserve">
    <value>Con-comitant Medication given</value>
  </data>
  <data name="Concomitant administration of cidofovir and other potentially nephrotoxic agents" xml:space="preserve">
    <value>Concomitant administration of cidofovir and other potentially nephrotoxic agents</value>
  </data>
  <data name="CONCOMITANT MEDICATIONS" xml:space="preserve">
    <value>CONCOMITANT MEDICATIONS</value>
  </data>
  <data name="CONCURRENT MEDICAL CONDITIONS AND \n MEDICATIONS" xml:space="preserve">
    <value>CONCURRENT MEDICAL CONDITIONS AND \n MEDICATIONS</value>
  </data>
  <data name="Confirm email" xml:space="preserve">
    <value>Confirm email</value>
  </data>
  <data name="Confirm password" xml:space="preserve">
    <value>Confirm password</value>
  </data>
  <data name="Confirm the safety profile of a medicine, or;" xml:space="preserve">
    <value>Confirm the safety profile of a medicine, or;</value>
  </data>
  <data name="Consent Form" xml:space="preserve">
    <value>Consent Form</value>
  </data>
  <data name="Contact" xml:space="preserve">
    <value>Contact</value>
  </data>
  <data name="Contact Address" xml:space="preserve">
    <value>Contact Address</value>
  </data>
  <data name="Contact Information" xml:space="preserve">
    <value>Contact Information</value>
  </data>
  <data name="Contact No" xml:space="preserve">
    <value>Contact No</value>
  </data>
  <data name="Contact Us" xml:space="preserve">
    <value>Contact Us</value>
  </data>
  <data name="Contactez nous" xml:space="preserve">
    <value>Contactez nous</value>
  </data>
  <data name="Contraindications" xml:space="preserve">
    <value>Contraindications</value>
  </data>
  <data name="Country" xml:space="preserve">
    <value>Country</value>
  </data>
  <data name="Creatinine" xml:space="preserve">
    <value>Creatinine</value>
  </data>
  <data name="Criteria for classifying as ‘Off-label Use’" xml:space="preserve">
    <value>Criteria for classifying as ‘Off-label Use’</value>
  </data>
  <data name="Date" xml:space="preserve">
    <value>Date</value>
  </data>
  <data name="Date of Acceptance" xml:space="preserve">
    <value>Date of Acceptance</value>
  </data>
  <data name="Date of Assessment" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="Date of Birth" xml:space="preserve">
    <value>Date of Birth</value>
  </data>
  <data name="Date participant/patient proxy signed written consent form" xml:space="preserve">
    <value>Date participant/patient proxy signed written consent form</value>
  </data>
  <data name="Deactivate" xml:space="preserve">
    <value>Deactivate</value>
  </data>
  <data name="Deactivated" xml:space="preserve">
    <value>Deactivated</value>
  </data>
  <data name="Death of patient" xml:space="preserve">
    <value>Death of patient</value>
  </data>
  <data name="Declined" xml:space="preserve">
    <value>Declined</value>
  </data>
  <data name="Delete" xml:space="preserve">
    <value>Delete</value>
  </data>
  <data name="Deleted" xml:space="preserve">
    <value>Deleted</value>
  </data>
  <data name="Demographic Data" xml:space="preserve">
    <value>Demographic Data</value>
  </data>
  <data name="Description" xml:space="preserve">
    <value>Description</value>
  </data>
  <data name="Did the patient have had any relevant Medical History?" xml:space="preserve">
    <value>Did the patient have had any relevant Medical History?</value>
  </data>
  <data name="Direct intraocular injection" xml:space="preserve">
    <value>Direct intraocular injection</value>
  </data>
  <data name="Doctor" xml:space="preserve">
    <value>Doctor</value>
  </data>
  <data name="Doctor or Pharmacist" xml:space="preserve">
    <value>Doctor or Pharmacist</value>
  </data>
  <data name="Doctor/Pharmacist" xml:space="preserve">
    <value>Doctor/Pharmacist</value>
  </data>
  <data name="Documentation of the Informed Consent" xml:space="preserve">
    <value>Documentation of the Informed Consent</value>
  </data>
  <data name="Dosage and units" xml:space="preserve">
    <value>Dosage and units</value>
  </data>
  <data name="Dose" xml:space="preserve">
    <value>Dose</value>
  </data>
  <data name="Dose &lt;small&gt;(including units)&lt;/small&gt;" xml:space="preserve">
    <value>Dose &lt;small&gt;(including units)&lt;/small&gt;</value>
  </data>
  <data name="Download" xml:space="preserve">
    <value>Download</value>
  </data>
  <data name="Download All Patient Data" xml:space="preserve">
    <value>Download All Patient Data</value>
  </data>
  <data name="Drop out" xml:space="preserve">
    <value>Drop out</value>
  </data>
  <data name="Edit" xml:space="preserve">
    <value>Edit</value>
  </data>
  <data name="Elderly population (&amp;gt; 60 years of age)" xml:space="preserve">
    <value>Elderly population (&amp;gt; 60 years of age)</value>
  </data>
  <data name="Email" xml:space="preserve">
    <value>Email</value>
  </data>
  <data name="Email1" xml:space="preserve">
    <value>Email1</value>
  </data>
  <data name="Enquiries relating to product availability where there are no pharmacovigilance consequences, referred to as product enquiry-related personal data &lt;b&gt;(hyperlink to specific policy)&lt;/b&gt;" xml:space="preserve">
    <value>Enquiries relating to product availability where there are no pharmacovigilance consequences, referred to as product enquiry-related personal data &lt;b&gt;(hyperlink to specific policy)&lt;/b&gt;</value>
  </data>
  <data name="Error" xml:space="preserve">
    <value>Error</value>
  </data>
  <data name="Error when fetching data please contact administrator" xml:space="preserve">
    <value>Error when fetching data please contact administrator</value>
  </data>
  <data name="Event Term &lt;small&gt;(Diagnosis if known)&lt;/small&gt;" xml:space="preserve">
    <value>Event Term &lt;small&gt;(Diagnosis if known)&lt;/small&gt;</value>
  </data>
  <data name="FAQs" xml:space="preserve">
    <value>FAQs</value>
  </data>
  <data name="Female" xml:space="preserve">
    <value>Female</value>
  </data>
  <data name="Femelle" xml:space="preserve">
    <value>Femelle</value>
  </data>
  <data name="Filter By Prescriber" xml:space="preserve">
    <value>Filter By Prescriber</value>
  </data>
  <data name="First Name" xml:space="preserve">
    <value>First Name</value>
  </data>
  <data name="FLH1" xml:space="preserve">
    <value>Adverse Events</value>
  </data>
  <data name="FLH2" xml:space="preserve">
    <value>Relevant Laboratory Investigations</value>
  </data>
  <data name="FLH3" xml:space="preserve">
    <value>Patient Outcome</value>
  </data>
  <data name="FLH4" xml:space="preserve">
    <value>Cidofovir Administration</value>
  </data>
  <data name="FLH5" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="FLH6" xml:space="preserve">
    <value>Medical Conditions and Medications</value>
  </data>
  <data name="FLH7" xml:space="preserve">
    <value>Prescriber's Sign-Off</value>
  </data>
  <data name="Follow Details" xml:space="preserve">
    <value>Follow Details</value>
  </data>
  <data name="Follow Up Form" xml:space="preserve">
    <value>Follow Up Form</value>
  </data>
  <data name="Follow up investigations" xml:space="preserve">
    <value>Follow up investigations</value>
  </data>
  <data name="For more information about Cidofovir or Tillomed, please do not hesitate to contact us." xml:space="preserve">
    <value>For more information about Cidofovir or Tillomed, please do not hesitate to contact us.</value>
  </data>
  <data name="for the above study and have had the opportunity to ask questions." xml:space="preserve">
    <value>for the above study and have had the opportunity to ask questions.</value>
  </data>
  <data name="Forgot Password" xml:space="preserve">
    <value>Forgot Password</value>
  </data>
  <data name="Forgot password confirmation" xml:space="preserve">
    <value>Forgot password confirmation</value>
  </data>
  <data name="Forgot your password?" xml:space="preserve">
    <value>Forgot your password?</value>
  </data>
  <data name="Foscarnet (for viral infection)" xml:space="preserve">
    <value>Foscarnet (for viral infection)</value>
  </data>
  <data name="Frequency" xml:space="preserve">
    <value>Frequency</value>
  </data>
  <data name="Frequency of administration" xml:space="preserve">
    <value>Frequency of administration</value>
  </data>
  <data name="FS1" xml:space="preserve">
    <value>Adverse Events</value>
  </data>
  <data name="FS2" xml:space="preserve">
    <value>Baseline Investigations</value>
  </data>
  <data name="FS3" xml:space="preserve">
    <value>Follow Up Investigations</value>
  </data>
  <data name="FS4" xml:space="preserve">
    <value>Patient Outcome</value>
  </data>
  <data name="FS5" xml:space="preserve">
    <value>Cidofovir Administration</value>
  </data>
  <data name="FS6" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="FS7" xml:space="preserve">
    <value>Concurrent Medical Conditions And Medications</value>
  </data>
  <data name="FS8" xml:space="preserve">
    <value>Prescriber's Sign Off</value>
  </data>
  <data name="FST1" xml:space="preserve">
    <value>Patient experienced any AEs</value>
  </data>
  <data name="FST10" xml:space="preserve">
    <value>Relationship to Study Drug</value>
  </data>
  <data name="FST100" xml:space="preserve">
    <value>Prescribers Email Id</value>
  </data>
  <data name="FST101" xml:space="preserve">
    <value>Registration Number</value>
  </data>
  <data name="FST102" xml:space="preserve">
    <value>Telephone Number</value>
  </data>
  <data name="FST103" xml:space="preserve">
    <value>Hospital Address</value>
  </data>
  <data name="FST104" xml:space="preserve">
    <value>Contact Address</value>
  </data>
  <data name="FST105" xml:space="preserve">
    <value>Date of Acceptance</value>
  </data>
  <data name="FST106" xml:space="preserve">
    <value>Save</value>
  </data>
  <data name="FST107" xml:space="preserve">
    <value />
  </data>
  <data name="FST108" xml:space="preserve">
    <value />
  </data>
  <data name="FST11" xml:space="preserve">
    <value>Has the patient been diagnosed with any malignancy since initiation of Cidofovir injection</value>
  </data>
  <data name="FST12" xml:space="preserve">
    <value>AE details</value>
  </data>
  <data name="FST13" xml:space="preserve">
    <value>I have reviewed all the AEs experienced, including outcome, seriousness, action taken with the medication and relationship with study drug and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this participant.</value>
  </data>
  <data name="FST14" xml:space="preserve">
    <value>Prescriber’s Name</value>
  </data>
  <data name="FST15" xml:space="preserve">
    <value>Date</value>
  </data>
  <data name="FST16" xml:space="preserve">
    <value>Specification</value>
  </data>
  <data name="FST17" xml:space="preserve">
    <value>Abnormal parameters, if any</value>
  </data>
  <data name="FST18" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST19" xml:space="preserve">
    <value>Haematology</value>
  </data>
  <data name="FST2" xml:space="preserve">
    <value>Adverse Events</value>
  </data>
  <data name="FST20" xml:space="preserve">
    <value>Biochemistry</value>
  </data>
  <data name="FST21" xml:space="preserve">
    <value>Urea</value>
  </data>
  <data name="FST22" xml:space="preserve">
    <value>Creatinine</value>
  </data>
  <data name="FST23" xml:space="preserve">
    <value>Phosphate</value>
  </data>
  <data name="FST24" xml:space="preserve">
    <value>Uric acid</value>
  </data>
  <data name="FST25" xml:space="preserve">
    <value>Bicarbonate</value>
  </data>
  <data name="FST26" xml:space="preserve">
    <value>Urine analysis (including glycosuria)</value>
  </data>
  <data name="FST27" xml:space="preserve">
    <value>Serology</value>
  </data>
  <data name="FST28" xml:space="preserve">
    <value>Others (Specify)</value>
  </data>
  <data name="FST29" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST3" xml:space="preserve">
    <value>Event Term (Diagnosis if known)</value>
  </data>
  <data name="FST30" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="FST31" xml:space="preserve">
    <value>Specification</value>
  </data>
  <data name="FST32" xml:space="preserve">
    <value>Abnormal parameters, if any</value>
  </data>
  <data name="FST33" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST34" xml:space="preserve">
    <value>Haematology</value>
  </data>
  <data name="FST35" xml:space="preserve">
    <value>Biochemistry</value>
  </data>
  <data name="FST36" xml:space="preserve">
    <value>Urea</value>
  </data>
  <data name="FST37" xml:space="preserve">
    <value>Creatinine</value>
  </data>
  <data name="FST38" xml:space="preserve">
    <value>Phosphate</value>
  </data>
  <data name="FST39" xml:space="preserve">
    <value>Uric acid</value>
  </data>
  <data name="FST4" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="FST40" xml:space="preserve">
    <value>Bicarbonate</value>
  </data>
  <data name="FST41" xml:space="preserve">
    <value>Urine analysis (including glycosuria)</value>
  </data>
  <data name="FST42" xml:space="preserve">
    <value>Serology</value>
  </data>
  <data name="FST43" xml:space="preserve">
    <value>Others (Specify)</value>
  </data>
  <data name="FST44" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST45" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="FST46" xml:space="preserve">
    <value>Please specify the patient’s outcome at this visit</value>
  </data>
  <data name="FST47" xml:space="preserve">
    <value>Treatment discontinued due to AE/SAE</value>
  </data>
  <data name="FST48" xml:space="preserve">
    <value>Underlying illness resolved</value>
  </data>
  <data name="FST49" xml:space="preserve">
    <value>Treatment regimen complete</value>
  </data>
  <data name="FST5" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="FST50" xml:space="preserve">
    <value>Death of patient</value>
  </data>
  <data name="FST51" xml:space="preserve">
    <value>Lost to follow-up</value>
  </data>
  <data name="FST52" xml:space="preserve">
    <value>Therapy to continue</value>
  </data>
  <data name="FST53" xml:space="preserve">
    <value>Withdrawal</value>
  </data>
  <data name="FST54" xml:space="preserve">
    <value>Please specify the reason</value>
  </data>
  <data name="FST55" xml:space="preserve">
    <value>Drop out</value>
  </data>
  <data name="FST56" xml:space="preserve">
    <value>Other outcomes</value>
  </data>
  <data name="FST57" xml:space="preserve">
    <value>Please specify</value>
  </data>
  <data name="FST58" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="FST59" xml:space="preserve">
    <value>Please state if any changes in treatment regimen were made with regards to the following</value>
  </data>
  <data name="FST6" xml:space="preserve">
    <value>SAE</value>
  </data>
  <data name="FST60" xml:space="preserve">
    <value>Indication</value>
  </data>
  <data name="FST61" xml:space="preserve">
    <value>Dose (including units)</value>
  </data>
  <data name="FST62" xml:space="preserve">
    <value>Frequency of administration</value>
  </data>
  <data name="FST63" xml:space="preserve">
    <value>Route of administration</value>
  </data>
  <data name="FST64" xml:space="preserve">
    <value>Remarks</value>
  </data>
  <data name="FST65" xml:space="preserve">
    <value>Please provide details regarding the final treatment regimen</value>
  </data>
  <data name="FST66" xml:space="preserve">
    <value>Total Dose Administered</value>
  </data>
  <data name="FST67" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="FST68" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="FST69" xml:space="preserve">
    <value>Total duration of treatment</value>
  </data>
  <data name="FST7" xml:space="preserve">
    <value>Con-comitant Medication given</value>
  </data>
  <data name="FST70" xml:space="preserve">
    <value>Remarks</value>
  </data>
  <data name="FST71" xml:space="preserve">
    <value>Did the patient have had any relevant Medical History?</value>
  </data>
  <data name="FST72" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="FST73" xml:space="preserve">
    <value>Please specify any significant/major illness, medical conditions or surgery in the past or at present.</value>
  </data>
  <data name="FST74" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="FST75" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="FST76" xml:space="preserve">
    <value>Or tick if Ongoing?</value>
  </data>
  <data name="FST77" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST78" xml:space="preserve">
    <value>Add More</value>
  </data>
  <data name="FST79" xml:space="preserve">
    <value>Save</value>
  </data>
  <data name="FST8" xml:space="preserve">
    <value>Study Drug Action</value>
  </data>
  <data name="FST80" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="FST81" xml:space="preserve">
    <value>Has the participant taken any concomitant medications at this follow-up</value>
  </data>
  <data name="FST82" xml:space="preserve">
    <value>Yes</value>
  </data>
  <data name="FST83" xml:space="preserve">
    <value>No</value>
  </data>
  <data name="FST84" xml:space="preserve">
    <value>Medications</value>
  </data>
  <data name="FST85" xml:space="preserve">
    <value>Medication (Record Generic or trade name)</value>
  </data>
  <data name="FST86" xml:space="preserve">
    <value>Reason for use (Medical History diagnosis or other reason, e.g. Prophylaxis)</value>
  </data>
  <data name="FST87" xml:space="preserve">
    <value>Dosage and units</value>
  </data>
  <data name="FST88" xml:space="preserve">
    <value>Route</value>
  </data>
  <data name="FST89" xml:space="preserve">
    <value>Frequency</value>
  </data>
  <data name="FST9" xml:space="preserve">
    <value>Outcome</value>
  </data>
  <data name="FST90" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="FST91" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="FST92" xml:space="preserve">
    <value>Or tick if on going at Screening Visit</value>
  </data>
  <data name="FST93" xml:space="preserve">
    <value>Comments</value>
  </data>
  <data name="FST94" xml:space="preserve">
    <value>Date of Assessment</value>
  </data>
  <data name="FST95" xml:space="preserve">
    <value>Add More</value>
  </data>
  <data name="FST96" xml:space="preserve">
    <value>Save</value>
  </data>
  <data name="FST97" xml:space="preserve">
    <value>Prescriber’s Statement</value>
  </data>
  <data name="FST98" xml:space="preserve">
    <value>I have reviewed this Follow-up Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient.</value>
  </data>
  <data name="FST99" xml:space="preserve">
    <value>Prescriber’s Name</value>
  </data>
  <data name="Healthcare Professionals" xml:space="preserve">
    <value>Healthcare Professionals</value>
  </data>
  <data name="Hello" xml:space="preserve">
    <value>Hello</value>
  </data>
  <data name="Home" xml:space="preserve">
    <value>Home</value>
  </data>
  <data name="Home Page" xml:space="preserve">
    <value>Home Page</value>
  </data>
  <data name="Hospital Address" xml:space="preserve">
    <value>Hospital Address</value>
  </data>
  <data name="How does the organisation protect data?" xml:space="preserve">
    <value>How does the organisation protect data?</value>
  </data>
  <data name="Hypersensitivity to the Cidofovir or to any of the excipients (Sodium hydroxide and hydrochloric acid)" xml:space="preserve">
    <value>Hypersensitivity to the Cidofovir or to any of the excipients (Sodium hydroxide and hydrochloric acid)</value>
  </data>
  <data name="I agree not to restrict the use of any data or results that arise from this study provided such a use is only for scientific purpose(s)" xml:space="preserve">
    <value>I agree not to restrict the use of any data or results that arise from this study provided such a use is only for scientific purpose(s)</value>
  </data>
  <data name="I agree to take part in the above study." xml:space="preserve">
    <value>I agree to take part in the above study.</value>
  </data>
  <data name="I confirm that I have read and understood the information sheet dated" xml:space="preserve">
    <value>I confirm that I have read and understood the information sheet dated</value>
  </data>
  <data name="I confirm that I have read and understood the information sheet dated &lt;lable id='date'&gt;&lt;/lable&gt; for the above study and have had the opportunity to ask questions." xml:space="preserve">
    <value>I confirm that I have read and understood the information sheet dated &lt;lable id='date'&gt;&lt;/lable&gt; for the above study and have had the opportunity to ask questions.</value>
  </data>
  <data name="I have read the above informationand it is presented in a language that I understand well. By signing this consent form, I attest that the information given in this document has been clearly explained to me and understood well by me. I have been told that I will be given a signed copy of thisform. I hereby willingly confirm that I wish to take part in this study." xml:space="preserve">
    <value>I have read the above informationand it is presented in a language that I understand well. By signing this consent form, I attest that the information given in this document has been clearly explained to me and understood well by me. I have been told that I will be given a signed copy of thisform. I hereby willingly confirm that I wish to take part in this study.</value>
  </data>
  <data name="I have reviewed all the AEs experienced, including outcome, seriousness, action taken with the medication and relationship with study drug and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this participant." xml:space="preserve">
    <value>I have reviewed all the AEs experienced, including outcome, seriousness, action taken with the medication and relationship with study drug and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this participant.</value>
  </data>
  <data name="I have reviewed this Baseline Data Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient." xml:space="preserve">
    <value>I have reviewed this Baseline Data Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient.</value>
  </data>
  <data name="I have reviewed this Follow-up Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient." xml:space="preserve">
    <value>I have reviewed this Follow-up Form and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient.</value>
  </data>
  <data name="I understand that all attempts will be made to protect my privacy and my family’s privacy. I understand that my personal information will be protected and saved in the Cidofovir Exposure Registry using a code." xml:space="preserve">
    <value>I understand that all attempts will be made to protect my privacy and my family’s privacy. I understand that my personal information will be protected and saved in the Cidofovir Exposure Registry using a code.</value>
  </data>
  <data name="I understand that all attempts will be made to protect my privacy and my family’s privacy. I understand that my personal information will be protected and saved in the Cidofovir Exposure Registryusingacode." xml:space="preserve">
    <value>I understand that all attempts will be made to protect my privacy and my family’s privacy. I understand that my personal information will be protected and saved in the Cidofovir Exposure Registryusingacode.</value>
  </data>
  <data name="I understand that I may not personally benefit from participating in the Cidofovir Exposure Registry." xml:space="preserve">
    <value>I understand that I may not personally benefit from participating in the Cidofovir Exposure Registry.</value>
  </data>
  <data name="I understand that I may not personally benefit from participating inthe Cidofovir Exposure Registry." xml:space="preserve">
    <value>I understand that I may not personally benefit from participating inthe Cidofovir Exposure Registry.</value>
  </data>
  <data name="I understand that my participation in the Study is voluntary and that I am free to withdraw at any time, without giving any reason, without my medical care or legal rights being affected." xml:space="preserve">
    <value>I understand that my participation in the Study is voluntary and that I am free to withdraw at any time, without giving any reason, without my medical care or legal rights being affected.</value>
  </data>
  <data name="I understand that my participation in the Study is voluntary and that I am free to withdrawat any time, withoutgiving any reason, without my medical care or legal rights being affected." xml:space="preserve">
    <value>I understand that my participation in the Study is voluntary and that I am free to withdrawat any time, withoutgiving any reason, without my medical care or legal rights being affected.</value>
  </data>
  <data name="I understand that the Sponsor of the Cidofovir Exposure Registry, others working on the Sponsor’s behalf, the Institutional Review Board and the regulatory authorities will not need my permission to look at my health records both in respect of the current study and any further research that may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. However, I understand that my identity will not be revealed in any information released to third parties or published." xml:space="preserve">
    <value>I understand that the Sponsor of the Cidofovir Exposure Registry, others working on the Sponsor’s behalf, the Institutional Review Board and the regulatory authorities will not need my permission to look at my health records both in respect of the current study and any further research that may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. However, I understand that my identity will not be revealed in any information released to third parties or published.</value>
  </data>
  <data name="I understand that the Sponsor of the Cidofovir Exposure Registry, others working on theSponsor’s behalf, the Institutional Review Board and the regulatory authorities will not need my permission to look at my health records both in respect of the current study and any further research that may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. However, I understand that my identity will not berevealed in any information released to third parties orpublished." xml:space="preserve">
    <value>I understand that the Sponsor of the Cidofovir Exposure Registry, others working on theSponsor’s behalf, the Institutional Review Board and the regulatory authorities will not need my permission to look at my health records both in respect of the current study and any further research that may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. However, I understand that my identity will not berevealed in any information released to third parties orpublished.</value>
  </data>
  <data name="Identify, characterise or quantify a safety hazard;" xml:space="preserve">
    <value>Identify, characterise or quantify a safety hazard;</value>
  </data>
  <data name="If any follow ups are conducted with your registered patient, please proceed to fill out the follow up form accordingly, which is available on the website. If you have entered any incorrect information in the follow up form, you will have the option to edit the data, upon approval from the lead sponsor. Multiple follow up forms will be available for completion for as many follow ups conducted with your registered patient(s)." xml:space="preserve">
    <value>If any follow ups are conducted with your registered patient, please proceed to fill out the follow up form accordingly, which is available on the website. If you have entered any incorrect information in the follow up form, you will have the option to edit the data, upon approval from the lead sponsor. Multiple follow up forms will be available for completion for as many follow ups conducted with your registered patient(s).</value>
  </data>
  <data name="If yes, please specify" xml:space="preserve">
    <value>If yes, please specify</value>
  </data>
  <data name="If you do not provide your personal data, the organisation may not be able to deal with your report or enquiry effectively, or at all." xml:space="preserve">
    <value>If you do not provide your personal data, the organisation may not be able to deal with your report or enquiry effectively, or at all.</value>
  </data>
  <data name="If you have entered any incorrect information in the baseline data form, you will have the option to edit the data, upon approval from the lead sponsor." xml:space="preserve">
    <value>If you have entered any incorrect information in the baseline data form, you will have the option to edit the data, upon approval from the lead sponsor.</value>
  </data>
  <data name="If you have queries or concerns regarding the registration process, please do not hesitate to contact us at" xml:space="preserve">
    <value>If you have queries or concerns regarding the registration process, please do not hesitate to contact us at</value>
  </data>
  <data name="If you would like to exercise any of these rights, please contact the Company Secretary by emailing &lt;a href='mailto:companysecretary@tillomed.co.uk' target='_blank'&gt;companysecretary@tillomed.co.uk.&lt;/a&gt; If you believe that the organisation has not complied with your data protection rights, you can complain to the Information Commissioner." xml:space="preserve">
    <value>If you would like to exercise any of these rights, please contact the Company Secretary by emailing &lt;a href='mailto:companysecretary@tillomed.co.uk' target='_blank'&gt;companysecretary@tillomed.co.uk.&lt;/a&gt; If you believe that the organisation has not complied with your data protection rights, you can complain to the Information Commissioner.</value>
  </data>
  <data name="In case the country of the patient is Germany no further data collection should take place thereafter. No further data should be collected on patients treated off-label# within the registry to comply with German Law." xml:space="preserve">
    <value>In case the country of the patient is Germany no further data collection should take place thereafter. No further data should be collected on patients treated off-label# within the registry to comply with German Law.</value>
  </data>
  <data name="INCLUSION CRITERIA" xml:space="preserve">
    <value>INCLUSION CRITERIA</value>
  </data>
  <data name="Indication" xml:space="preserve">
    <value>Indication</value>
  </data>
  <data name="INFORMED CONSENT" xml:space="preserve">
    <value>INFORMED CONSENT</value>
  </data>
  <data name="Informed Consent and Eligibility" xml:space="preserve">
    <value>Informed Consent and Eligibility</value>
  </data>
  <data name="Informed Consent Form" xml:space="preserve">
    <value>Informed Consent Form</value>
  </data>
  <data name="Informed Consent Given" xml:space="preserve">
    <value>Informed Consent Given</value>
  </data>
  <data name="Instructions" xml:space="preserve">
    <value>Instructions</value>
  </data>
  <data name="Is the patient exposed to Emcure’s Cidofovir 75mg/ml concentrate for solution for infusion under any of the following conditions" xml:space="preserve">
    <value>Is the patient exposed to Emcure’s Cidofovir 75mg/ml concentrate for solution for infusion under any of the following conditions</value>
  </data>
  <data name="Is the patient exposed to Emcure’s Cidofovir 75mg/mlconcentrate for solution for infusion?" xml:space="preserve">
    <value>Is the patient exposed to Emcure’s Cidofovir 75mg/mlconcentrate for solution for infusion?</value>
  </data>
  <data name="Is the patient or patient proxy (in event the patient is  unable to consent) willing to provide written informedconsent?" xml:space="preserve">
    <value>Is the patient or patient proxy (in event the patient is  unable to consent) willing to provide written informedconsent?</value>
  </data>
  <data name="Is the patient taking any concomitant medications at screening?" xml:space="preserve">
    <value>Is the patient taking any concomitant medications at screening?</value>
  </data>
  <data name="LABORATORY INVESTIGATIONS" xml:space="preserve">
    <value>LABORATORY INVESTIGATIONS</value>
  </data>
  <data name="Last Name" xml:space="preserve">
    <value>Last Name</value>
  </data>
  <data name="Log in" xml:space="preserve">
    <value>Log in</value>
  </data>
  <data name="Login" xml:space="preserve">
    <value>Login</value>
  </data>
  <data name="Logout" xml:space="preserve">
    <value>Logout</value>
  </data>
  <data name="Lost to follow-up" xml:space="preserve">
    <value>Lost to follow-up</value>
  </data>
  <data name="Male" xml:space="preserve">
    <value>Male</value>
  </data>
  <data name="Manage Profile" xml:space="preserve">
    <value>Manage Profile</value>
  </data>
  <data name="Measure the effectiveness of risk-management measures." xml:space="preserve">
    <value>Measure the effectiveness of risk-management measures.</value>
  </data>
  <data name="Medical Conditions And Medical Conditions And Medications" xml:space="preserve">
    <value>Medical Conditions And Medical Conditions And Medications</value>
  </data>
  <data name="Medical enquiries about products where there are no pharmacovigilance consequences, referred to as &lt;b&gt;medical enquiry-related personal data (hyperlink to specific policy)&lt;/b&gt;" xml:space="preserve">
    <value>Medical enquiries about products where there are no pharmacovigilance consequences, referred to as &lt;b&gt;medical enquiry-related personal data (hyperlink to specific policy)&lt;/b&gt;</value>
  </data>
  <data name="Medical History" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="Medication" xml:space="preserve">
    <value>Medication</value>
  </data>
  <data name="Medication &lt;small&gt;(Record Generic or trade name)&lt;/small&gt;" xml:space="preserve">
    <value>Medication &lt;small&gt;(Record Generic or trade name)&lt;/small&gt;</value>
  </data>
  <data name="Medications" xml:space="preserve">
    <value>Medications</value>
  </data>
  <data name="Modifiez vos paramètres de compte" xml:space="preserve">
    <value>Modifiez vos paramètres de compte</value>
  </data>
  <data name="Médecin ou pharmacien" xml:space="preserve">
    <value>Médecin ou pharmacien</value>
  </data>
  <data name="Name" xml:space="preserve">
    <value>Name</value>
  </data>
  <data name="Name of the legal representative, if applicable" xml:space="preserve">
    <value>Name of the legal representative, if applicable</value>
  </data>
  <data name="Name of the patient" xml:space="preserve">
    <value>Name of the patient</value>
  </data>
  <data name="New Requested" xml:space="preserve">
    <value>New Requested</value>
  </data>
  <data name="No" xml:space="preserve">
    <value>No</value>
  </data>
  <data name="No decisions are based solely on automated data processing." xml:space="preserve">
    <value>No decisions are based solely on automated data processing.</value>
  </data>
  <data name="Non Applicable" xml:space="preserve">
    <value>Non Applicable</value>
  </data>
  <data name="Object to the processing of your data where the organisation is relying on its legitimate interests as the legal ground for processing." xml:space="preserve">
    <value>Object to the processing of your data where the organisation is relying on its legitimate interests as the legal ground for processing.</value>
  </data>
  <data name="Off-label" xml:space="preserve">
    <value>Off-label</value>
  </data>
  <data name="Ok" xml:space="preserve">
    <value>Ok</value>
  </data>
  <data name="On-label" xml:space="preserve">
    <value>On-label</value>
  </data>
  <data name="Once approved, a Prescribers Reference ID will be generated and assigned to yourself via email from the lead sponsor, allowing you to proceed to fill out the baseline data form accordingly, which is available to you on the website." xml:space="preserve">
    <value>Once approved, a Prescribers Reference ID will be generated and assigned to yourself via email from the lead sponsor, allowing you to proceed to fill out the baseline data form accordingly, which is available to you on the website.</value>
  </data>
  <data name="Once the informed consent form has been completed and signed by the patient, please proceed to upload a scanned copy of the document, and we request you to shred the physical copy for privacy purposes, unless otherwise stated as per your organisations’ privacy procedures." xml:space="preserve">
    <value>Once the informed consent form has been completed and signed by the patient, please proceed to upload a scanned copy of the document, and we request you to shred the physical copy for privacy purposes, unless otherwise stated as per your organisations’ privacy procedures.</value>
  </data>
  <data name="Once you delete, it can not be retrieved." xml:space="preserve">
    <value>Once you delete, it can not be retrieved.</value>
  </data>
  <data name="or" xml:space="preserve">
    <value>or</value>
  </data>
  <data name="Or tick if on going at Screening Visit" xml:space="preserve">
    <value>Or tick if on going at Screening Visit</value>
  </data>
  <data name="Or tick if Ongoing?" xml:space="preserve">
    <value>Or tick if Ongoing?</value>
  </data>
  <data name="Other Indication, please specify:&lt;small&gt;(Off-label)&lt;/small&gt;" xml:space="preserve">
    <value>Other Indication, please specify:&lt;small&gt;(Off-label)&lt;/small&gt;</value>
  </data>
  <data name="Other medicines and cidofovir" xml:space="preserve">
    <value>Other medicines and cidofovir</value>
  </data>
  <data name="Other outcomes" xml:space="preserve">
    <value>Other outcomes</value>
  </data>
  <data name="Other Specialization" xml:space="preserve">
    <value>Other Specialization</value>
  </data>
  <data name="Others (Specify)" xml:space="preserve">
    <value>Others (Specify)</value>
  </data>
  <data name="Outcome" xml:space="preserve">
    <value>Outcome</value>
  </data>
  <data name="Pass Study" xml:space="preserve">
    <value>Pass Study</value>
  </data>
  <data name="Password" xml:space="preserve">
    <value>Password</value>
  </data>
  <data name="Patient Details" xml:space="preserve">
    <value>Patient Details</value>
  </data>
  <data name="Patient experienced any AEs" xml:space="preserve">
    <value>Patient experienced any AEs</value>
  </data>
  <data name="Patient Id" xml:space="preserve">
    <value>Patient Id</value>
  </data>
  <data name="Patient List" xml:space="preserve">
    <value>Patient List</value>
  </data>
  <data name="Patient Outcome" xml:space="preserve">
    <value>Patient Outcome</value>
  </data>
  <data name="Patients unable to receive probenecid or other sulfa containing medication" xml:space="preserve">
    <value>Patients unable to receive probenecid or other sulfa containing medication</value>
  </data>
  <data name="Patients with renal insufficiency" xml:space="preserve">
    <value>Patients with renal insufficiency</value>
  </data>
  <data name="Pediatric population (&amp;lt; 18 years of age)" xml:space="preserve">
    <value>Pediatric population (&amp;lt; 18 years of age)</value>
  </data>
  <data name="Pharmacist" xml:space="preserve">
    <value>Pharmacist</value>
  </data>
  <data name="Phosphate" xml:space="preserve">
    <value>Phosphate</value>
  </data>
  <data name="Please check your email to reset your password." xml:space="preserve">
    <value>Please check your email to reset your password.</value>
  </data>
  <data name="Please enter exactly 10 digits" xml:space="preserve">
    <value>Please enter exactly 10 digits</value>
  </data>
  <data name="Please fill required fields, in every section." xml:space="preserve">
    <value>Please fill required fields, in every section.</value>
  </data>
  <data name="Please provide details regarding the final treatment regimen" xml:space="preserve">
    <value>Please provide details regarding the final treatment regimen</value>
  </data>
  <data name="Please provide the following details regarding the intended treatment regimen" xml:space="preserve">
    <value>Please provide the following details regarding the intended treatment regimen</value>
  </data>
  <data name="Please see below instructions on how to register patients for the study" xml:space="preserve">
    <value>Please see below instructions on how to register patients for the study</value>
  </data>
  <data name="Please select Specialization" xml:space="preserve">
    <value>Please select Specialization</value>
  </data>
  <data name="Please specify" xml:space="preserve">
    <value>Please specify</value>
  </data>
  <data name="Please specify any significant/major illness, medical conditions or surgery in the past or at present." xml:space="preserve">
    <value>Please specify any significant/major illness, medical conditions or surgery in the past or at present.</value>
  </data>
  <data name="Please specify the patient’s outcome at this visit" xml:space="preserve">
    <value>Please specify the patient’s outcome at this visit</value>
  </data>
  <data name="Please state if any changes in treatment regimen were made with regards to the following" xml:space="preserve">
    <value>Please state if any changes in treatment regimen were made with regards to the following</value>
  </data>
  <data name="Posology and Method of administration" xml:space="preserve">
    <value>Posology and Method of administration</value>
  </data>
  <data name="Possible side effects" xml:space="preserve">
    <value>Possible side effects</value>
  </data>
  <data name="Pregnant and Lactating Females, Females of child-bearing potential not using contraception" xml:space="preserve">
    <value>Pregnant and Lactating Females, Females of child-bearing potential not using contraception</value>
  </data>
  <data name="Prescriber Index" xml:space="preserve">
    <value>Prescriber Index</value>
  </data>
  <data name="Prescribers Email Id" xml:space="preserve">
    <value>Prescribers Email Id</value>
  </data>
  <data name="Prescriber’s Name" xml:space="preserve">
    <value>Prescriber’s Name</value>
  </data>
  <data name="Prescriber’s Statement" xml:space="preserve">
    <value>Prescriber’s Statement</value>
  </data>
  <data name="Print Form" xml:space="preserve">
    <value>Print Form</value>
  </data>
  <data name="Privacy notice" xml:space="preserve">
    <value>Privacy notice</value>
  </data>
  <data name="Privacy Policy" xml:space="preserve">
    <value>Privacy Policy</value>
  </data>
  <data name="Prénom" xml:space="preserve">
    <value>Prénom</value>
  </data>
  <data name="Reason for use &lt;small&gt;(Medical History diagnosis or other reason, e.g. Prophylaxis)&lt;/small&gt;" xml:space="preserve">
    <value>Reason for use &lt;small&gt;(Medical History diagnosis or other reason, e.g. Prophylaxis)&lt;/small&gt;</value>
  </data>
  <data name="Record has been added successfully." xml:space="preserve">
    <value>Record has been added successfully.</value>
  </data>
  <data name="Record has been Approved successfully." xml:space="preserve">
    <value>Record has been Approved successfully.</value>
  </data>
  <data name="Record has been Deactivated successfully." xml:space="preserve">
    <value>Record has been Deactivated successfully.</value>
  </data>
  <data name="Record has been deleted successfully." xml:space="preserve">
    <value>Record has been deleted successfully.</value>
  </data>
  <data name="Record has been Rejected successfully." xml:space="preserve">
    <value>Record has been Rejected successfully.</value>
  </data>
  <data name="Register" xml:space="preserve">
    <value>Register</value>
  </data>
  <data name="Registered Patients" xml:space="preserve">
    <value>Registered Patients</value>
  </data>
  <data name="Registered Patients List" xml:space="preserve">
    <value>Registered Patients List</value>
  </data>
  <data name="Registration Number" xml:space="preserve">
    <value>Registration Number</value>
  </data>
  <data name="Registry Information" xml:space="preserve">
    <value>Registry Information</value>
  </data>
  <data name="Reject" xml:space="preserve">
    <value>Reject</value>
  </data>
  <data name="Rejected" xml:space="preserve">
    <value>Rejected</value>
  </data>
  <data name="Relationship to Study Drug" xml:space="preserve">
    <value>Relationship to Study Drug</value>
  </data>
  <data name="Relevant Laboratory Investigations" xml:space="preserve">
    <value>Relevant Laboratory Investigations</value>
  </data>
  <data name="Remarks" xml:space="preserve">
    <value>Remarks</value>
  </data>
  <data name="Remember me" xml:space="preserve">
    <value>Remember me</value>
  </data>
  <data name="Remove Last" xml:space="preserve">
    <value>Remove Last</value>
  </data>
  <data name="Reports of adverse effects potentially arising from consumption of products referred to as &lt;b&gt;PV-related personal data (hyperlink to specific policy)&lt;/b&gt;" xml:space="preserve">
    <value>Reports of adverse effects potentially arising from consumption of products referred to as &lt;b&gt;PV-related personal data (hyperlink to specific policy)&lt;/b&gt;</value>
  </data>
  <data name="Reports of potential product quality defects where there are no pharmacovigilance consequences, referred to as &lt;b&gt;product quality complaint-related personal data (hyperlink to specific policy)&lt;/b&gt;" xml:space="preserve">
    <value>Reports of potential product quality defects where there are no pharmacovigilance consequences, referred to as &lt;b&gt;product quality complaint-related personal data (hyperlink to specific policy)&lt;/b&gt;</value>
  </data>
  <data name="Require the organisation to delete or stop processing your data, for example where the data is no longer necessary for the purposes of processing; and" xml:space="preserve">
    <value>Require the organisation to delete or stop processing your data, for example where the data is no longer necessary for the purposes of processing; and</value>
  </data>
  <data name="Reset" xml:space="preserve">
    <value>Reset</value>
  </data>
  <data name="Reset password confirmation" xml:space="preserve">
    <value>Reset password confirmation</value>
  </data>
  <data name="Route" xml:space="preserve">
    <value>Route</value>
  </data>
  <data name="Route of administration &lt;small&gt;(IV, Intraocular, Topical, etc.)&lt;/small&gt;" xml:space="preserve">
    <value>Route of administration &lt;small&gt;(IV, Intraocular, Topical, etc.)&lt;/small&gt;</value>
  </data>
  <data name="SAE" xml:space="preserve">
    <value>SAE</value>
  </data>
  <data name="Save" xml:space="preserve">
    <value>Save</value>
  </data>
  <data name="Security Question" xml:space="preserve">
    <value>Security Question</value>
  </data>
  <data name="Send" xml:space="preserve">
    <value>Send</value>
  </data>
  <data name="Serology" xml:space="preserve">
    <value>Serology</value>
  </data>
  <data name="Sex" xml:space="preserve">
    <value>Sex</value>
  </data>
  <data name="Signature" xml:space="preserve">
    <value>Signature</value>
  </data>
  <data name="Signature of the patient/legal representative confirming that he/she understood the content of the consent form" xml:space="preserve">
    <value>Signature of the patient/legal representative confirming that he/she understood the content of the consent form</value>
  </data>
  <data name="Signatureof the patient/legal representative confirming that he/she understood the content of the consent form" xml:space="preserve">
    <value>Signatureof the patient/legal representative confirming that he/she understood the content of the consent form</value>
  </data>
  <data name="Some text in the modal." xml:space="preserve">
    <value>Some text in the modal.</value>
  </data>
  <data name="Specialisation" xml:space="preserve">
    <value>Specialisation</value>
  </data>
  <data name="Specification" xml:space="preserve">
    <value>Specification</value>
  </data>
  <data name="Sr. No." xml:space="preserve">
    <value>Sr. No.</value>
  </data>
  <data name="Sr.No." xml:space="preserve">
    <value>Sr.No.</value>
  </data>
  <data name="Start Date" xml:space="preserve">
    <value>Start Date</value>
  </data>
  <data name="Status" xml:space="preserve">
    <value>Status</value>
  </data>
  <data name="Stop Date" xml:space="preserve">
    <value>Stop Date</value>
  </data>
  <data name="Study Drug Action" xml:space="preserve">
    <value>Study Drug Action</value>
  </data>
  <data name="Study Title" xml:space="preserve">
    <value>Study Title</value>
  </data>
  <data name="Success" xml:space="preserve">
    <value>Success</value>
  </data>
  <data name="Telephone" xml:space="preserve">
    <value>Telephone</value>
  </data>
  <data name="Telephone Number" xml:space="preserve">
    <value>Telephone Number</value>
  </data>
  <data name="Tenofovir containing medicines, used to treat HIV-1 infection and/or chronic hepatitis B infection aminoglycosides, pentamidine or vancomycin (for bacterial infections)" xml:space="preserve">
    <value>Tenofovir containing medicines, used to treat HIV-1 infection and/or chronic hepatitis B infection aminoglycosides, pentamidine or vancomycin (for bacterial infections)</value>
  </data>
  <data name="Thank you for confirming your email." xml:space="preserve">
    <value>Thank you for confirming your email.</value>
  </data>
  <data name="Thank you for your interest in the Cidofovir registry study. If you would like to participate in the study, please click on the ‘register’ link and fill the details as requested." xml:space="preserve">
    <value>Thank you for your interest in the Cidofovir registry study. If you would like to participate in the study, please click on the ‘register’ link and fill the details as requested.</value>
  </data>
  <data name="Thank you registering your interest in Tillomed’s Cidofovir Exposure Registry Study" xml:space="preserve">
    <value>Thank you registering your interest in Tillomed’s Cidofovir Exposure Registry Study</value>
  </data>
  <data name="The data controller will be the holder of the marketing authorisation for the relevant product: Tillomed Laboratories Limited (UK), Tillomed Pharma GMBH (Germany or Belgium), Laboratorios Tillomed Spain (Spain)." xml:space="preserve">
    <value>The data controller will be the holder of the marketing authorisation for the relevant product: Tillomed Laboratories Limited (UK), Tillomed Pharma GMBH (Germany or Belgium), Laboratorios Tillomed Spain (Spain).</value>
  </data>
  <data name="The following criteria MUST be answered YES for participant to be included in the study. In case any of the criterion is NO, the patient will not be eligible to participate in the study" xml:space="preserve">
    <value>The following criteria MUST be answered YES for participant to be included in the study. In case any of the criterion is NO, the patient will not be eligible to participate in the study</value>
  </data>
  <data name="The lead sponsor will review the informed consent form accordingly and either approve or reject the patient registration which will be notified to you via email. Rejection will occur in the case of any incomplete information provided and we will prompt you to provide the missing information." xml:space="preserve">
    <value>The lead sponsor will review the informed consent form accordingly and either approve or reject the patient registration which will be notified to you via email. Rejection will occur in the case of any incomplete information provided and we will prompt you to provide the missing information.</value>
  </data>
  <data name="The organisation collects and processes personal data relating to:" xml:space="preserve">
    <value>The organisation collects and processes personal data relating to:</value>
  </data>
  <data name="The organisation is committed to being transparent about how it collects and uses that data and to meeting its data protection obligations." xml:space="preserve">
    <value>The organisation is committed to being transparent about how it collects and uses that data and to meeting its data protection obligations.</value>
  </data>
  <data name="The organisation takes the security of your data seriously. The organisation has internal policies and controls in place to try to ensure that your data is not lost, accidentally destroyed, misused or disclosed, and is not accessed except by its employees in the performance of their duties." xml:space="preserve">
    <value>The organisation takes the security of your data seriously. The organisation has internal policies and controls in place to try to ensure that your data is not lost, accidentally destroyed, misused or disclosed, and is not accessed except by its employees in the performance of their duties.</value>
  </data>
  <data name="The password and confirmation password do not match." xml:space="preserve">
    <value>The password and confirmation password do not match.</value>
  </data>
  <data name="The {0} must be at least {2} and at max {1} characters long." xml:space="preserve">
    <value>The {0} must be at least {2} and at max {1} characters long.</value>
  </data>
  <data name="Therapy to continue" xml:space="preserve">
    <value>Therapy to continue</value>
  </data>
  <data name="This is an observational/non-interventional, multi-centre, multi-national, Cidofovir Exposure Registry based, cohort study with prospective patient enrolment and follow-up. This registry will spread across UK, France, Germany and Spain. The aim of this registry is to collect safety data in patients being prescribed Emcure’s Cidofovir formulation (Cidofovir Emcure Pharma 75 mg/ml Concentrate for Solution for Infusion). The information collected in this registry will be used to understand the pattern of side effects of Cidofovir use and the medical condition for which Cidofovir is being prescribed by you. This is a long term exposure study which would enable to identify new safety information of Cidofovir." xml:space="preserve">
    <value>This is an observational/non-interventional, multi-centre, multi-national, Cidofovir Exposure Registry based, cohort study with prospective patient enrolment and follow-up. This registry will spread across UK, France, Germany and Spain. The aim of this registry is to collect safety data in patients being prescribed Emcure’s Cidofovir formulation (Cidofovir Emcure Pharma 75 mg/ml Concentrate for Solution for Infusion). The information collected in this registry will be used to understand the pattern of side effects of Cidofovir use and the medical condition for which Cidofovir is being prescribed by you. This is a long term exposure study which would enable to identify new safety information of Cidofovir.</value>
  </data>
  <data name="Tillomed group of companies (each referred to in this privacy notice as ‘organisation‘) collect and process personal data belonging to a number of categories of individuals." xml:space="preserve">
    <value>Tillomed group of companies (each referred to in this privacy notice as ‘organisation‘) collect and process personal data belonging to a number of categories of individuals.</value>
  </data>
  <data name="Tillomed is a European Pharmaceutical company with headquarters in the UK and subsidiaries in France, Spain, Germany, Italy and MENA." xml:space="preserve">
    <value>Tillomed is a European Pharmaceutical company with headquarters in the UK and subsidiaries in France, Spain, Germany, Italy and MENA.</value>
  </data>
  <data name="Tillomed is owned by Emcure Pharma UK Ltd. one of India's leading pharmaceutical companies." xml:space="preserve">
    <value>Tillomed is owned by Emcure Pharma UK Ltd. one of India's leading pharmaceutical companies.</value>
  </data>
  <data name="Tillomed specialises in the licensing and marketing of generic pharmaceuticals which meet genuine needs and deliver effective, high-quality, sustainable healthcare." xml:space="preserve">
    <value>Tillomed specialises in the licensing and marketing of generic pharmaceuticals which meet genuine needs and deliver effective, high-quality, sustainable healthcare.</value>
  </data>
  <data name="Time" xml:space="preserve">
    <value>Time</value>
  </data>
  <data name="To assess patient outcome following treatment in specified indication." xml:space="preserve">
    <value>To assess patient outcome following treatment in specified indication.</value>
  </data>
  <data name="To evaluate patterns and incidence of the occurrence of adverse events in patients who are being treated for the indication authorized for Cidofovir as against any other indication for which it may be prescribed." xml:space="preserve">
    <value>To evaluate patterns and incidence of the occurrence of adverse events in patients who are being treated for the indication authorized for Cidofovir as against any other indication for which it may be prescribed.</value>
  </data>
  <data name="To identify the indications and patient populations for Cidofovir use." xml:space="preserve">
    <value>To identify the indications and patient populations for Cidofovir use.</value>
  </data>
  <data name="Total Dose Administered" xml:space="preserve">
    <value>Total Dose Administered</value>
  </data>
  <data name="Total duration of treatment" xml:space="preserve">
    <value>Total duration of treatment</value>
  </data>
  <data name="Treatment discontinued due to AE/SAE" xml:space="preserve">
    <value>Treatment discontinued due to AE/SAE</value>
  </data>
  <data name="Treatment Init Details" xml:space="preserve">
    <value>Treatment Init Details</value>
  </data>
  <data name="Treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction. It should be used only when other medicinal products are considered unsuitable." xml:space="preserve">
    <value>Treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction. It should be used only when other medicinal products are considered unsuitable.</value>
  </data>
  <data name="Treatment regimen complete" xml:space="preserve">
    <value>Treatment regimen complete</value>
  </data>
  <data name="Underlying illness resolved" xml:space="preserve">
    <value>Underlying illness resolved</value>
  </data>
  <data name="Upon receiving approval from the lead sponsor for your successful HCP registration via email, when you are prescribing a patient with Cidofovir, please present them with the synopsis provided in the packaging of Tillomed Cidofovir detailing the rationale and objectives for this study. If patient is willing to participate in the study, please proceed to present them with the informed consent form for their completion and signature, which is available on the website." xml:space="preserve">
    <value>Upon receiving approval from the lead sponsor for your successful HCP registration via email, when you are prescribing a patient with Cidofovir, please present them with the synopsis provided in the packaging of Tillomed Cidofovir detailing the rationale and objectives for this study. If patient is willing to participate in the study, please proceed to present them with the informed consent form for their completion and signature, which is available on the website.</value>
  </data>
  <data name="Upon successful uploading and approval of the baseline data form from lead sponsor via email, your patient will be successfully registered onto the study and will be assigned and Patient Reference ID." xml:space="preserve">
    <value>Upon successful uploading and approval of the baseline data form from lead sponsor via email, your patient will be successfully registered onto the study and will be assigned and Patient Reference ID.</value>
  </data>
  <data name="Urea" xml:space="preserve">
    <value>Urea</value>
  </data>
  <data name="Uric acid" xml:space="preserve">
    <value>Uric acid</value>
  </data>
  <data name="Urine analysis (including glycosuria)" xml:space="preserve">
    <value>Urine analysis (including glycosuria)</value>
  </data>
  <data name="Use in Special Populations" xml:space="preserve">
    <value>Use in Special Populations</value>
  </data>
  <data name="Verification Code" xml:space="preserve">
    <value>Verification Code</value>
  </data>
  <data name="View" xml:space="preserve">
    <value>View</value>
  </data>
  <data name="View Details" xml:space="preserve">
    <value>View Details</value>
  </data>
  <data name="View Prescriber" xml:space="preserve">
    <value>View Prescriber</value>
  </data>
  <data name="View Prescriber Details" xml:space="preserve">
    <value>View Prescriber Details</value>
  </data>
  <data name="WE CARE ABOUT YOUR &lt;span&gt;HEALTH&lt;/span&gt;" xml:space="preserve">
    <value>WE CARE ABOUT YOUR &lt;span&gt;HEALTH&lt;/span&gt;</value>
  </data>
  <data name="We will be pleased to answer any questions or queries you may have." xml:space="preserve">
    <value>We will be pleased to answer any questions or queries you may have.</value>
  </data>
  <data name="We're sorry, page you're looking for is, sadly, not here." xml:space="preserve">
    <value>We're sorry, page you're looking for is, sadly, not here.</value>
  </data>
  <data name="Welcome to" xml:space="preserve">
    <value>Welcome to</value>
  </data>
  <data name="Welcome to the &lt;span&gt;Cidofovir&lt;/span&gt; Exposure Registry of Emcure Pharma UK Ltd." xml:space="preserve">
    <value>Welcome to the &lt;span&gt;Cidofovir&lt;/span&gt; Exposure Registry of Emcure Pharma UK Ltd.</value>
  </data>
  <data name="What Cidofovir is and what it is used for?" xml:space="preserve">
    <value>What Cidofovir is and what it is used for?</value>
  </data>
  <data name="What if you do not provide personal data?" xml:space="preserve">
    <value>What if you do not provide personal data?</value>
  </data>
  <data name="What information the organisation collects?" xml:space="preserve">
    <value>What information the organisation collects?</value>
  </data>
  <data name="What you need to know before you use Cidofovir" xml:space="preserve">
    <value>What you need to know before you use Cidofovir</value>
  </data>
  <data name="Where the information comes from?" xml:space="preserve">
    <value>Where the information comes from?</value>
  </data>
  <data name="Where the organisation engages third parties to process personal data on its behalf, they do so on the basis of written instructions, are under a duty of confidentiality and are obliged to implement appropriate technical and organisational measures to ensure the security of data." xml:space="preserve">
    <value>Where the organisation engages third parties to process personal data on its behalf, they do so on the basis of written instructions, are under a duty of confidentiality and are obliged to implement appropriate technical and organisational measures to ensure the security of data.</value>
  </data>
  <data name="Who your data will be disclosed to?" xml:space="preserve">
    <value>Who your data will be disclosed to?</value>
  </data>
  <data name="Why your data is processed, where we store it and for how long we retain it?" xml:space="preserve">
    <value>Why your data is processed, where we store it and for how long we retain it?</value>
  </data>
  <data name="Withdrawal" xml:space="preserve">
    <value>Withdrawal</value>
  </data>
  <data name="Yes" xml:space="preserve">
    <value>Yes</value>
  </data>
  <data name="You can access more information using the links above to pages which explain:" xml:space="preserve">
    <value>You can access more information using the links above to pages which explain:</value>
  </data>
  <data name="You do not have access to this resource." xml:space="preserve">
    <value>You do not have access to this resource.</value>
  </data>
  <data name="Your password has been reset" xml:space="preserve">
    <value>Your password has been reset</value>
  </data>
  <data name="Your rights" xml:space="preserve">
    <value>Your rights</value>
  </data>
  <data name="Study" xml:space="preserve">
    <value>Study</value>
  </data>
  <data name="Please select Question" xml:space="preserve">
    <value>Please select Question</value>
  </data>
  <data name="Please select Specialisation" xml:space="preserve">
    <value>Please select Specialisation</value>
  </data>
  <data name="All Prescriber" xml:space="preserve">
    <value>All Prescriber</value>
  </data>
  <data name="Saved Successfully" xml:space="preserve">
    <value>Saved Successfully</value>
  </data>
  <data name="Updated Successfully" xml:space="preserve">
    <value>Updated Successfully</value>
  </data>
  <data name="Activated Successfully" xml:space="preserve">
    <value>Activated Successfully</value>
  </data>
  <data name="Approved Successfully" xml:space="preserve">
    <value>Approved Successfully</value>
  </data>
  <data name="Approved1" xml:space="preserve">
    <value>Approved</value>
  </data>
  <data name="Authentication Security Question" xml:space="preserve">
    <value>Authentication Security Question</value>
  </data>
  <data name="Change password" xml:space="preserve">
    <value>Change password</value>
  </data>
  <data name="Change your account settings" xml:space="preserve">
    <value>Change your account settings</value>
  </data>
  <data name="Confirm new password" xml:space="preserve">
    <value>Confirm new password</value>
  </data>
  <data name="Cover Letter" xml:space="preserve">
    <value>Cover Letter</value>
  </data>
  <data name="Current password" xml:space="preserve">
    <value>Current password</value>
  </data>
  <data name="Deactivated Successfully" xml:space="preserve">
    <value>Deactivated Successfully</value>
  </data>
  <data name="Deleted Successfully" xml:space="preserve">
    <value>Deleted Successfully</value>
  </data>
  <data name="Manage your account" xml:space="preserve">
    <value>Manage your account</value>
  </data>
  <data name="New password" xml:space="preserve">
    <value>New password</value>
  </data>
  <data name="Partially Approved" xml:space="preserve">
    <value>Partially Approved</value>
  </data>
  <data name="Partially Rejected" xml:space="preserve">
    <value>Partially Rejected</value>
  </data>
  <data name="Pending Approval" xml:space="preserve">
    <value>Pending Approval</value>
  </data>
  <data name="Prescriber’s Guide" xml:space="preserve">
    <value>Prescriber’s Guide</value>
  </data>
  <data name="Product" xml:space="preserve">
    <value>Product</value>
  </data>
  <data name="Profile" xml:space="preserve">
    <value>Profile</value>
  </data>
  <data name="Protocol Synopsis" xml:space="preserve">
    <value>Protocol Synopsis</value>
  </data>
  <data name="Question" xml:space="preserve">
    <value>Question</value>
  </data>
  <data name="Regular Error" xml:space="preserve">
    <value>Regular Error</value>
  </data>
  <data name="Rejected Successfully" xml:space="preserve">
    <value>Rejected Successfully</value>
  </data>
  <data name="The new password and confirmation password do not match." xml:space="preserve">
    <value>The new password and confirmation password do not match.</value>
  </data>
  <data name="The {0} must be at least {2} characters long." xml:space="preserve">
    <value>The {0} must be at least {2} characters long.</value>
  </data>
  <data name="Username" xml:space="preserve">
    <value>Username</value>
  </data>
  <data name="Your credentials for the Tillomed portal" xml:space="preserve">
    <value>Your credentials for the Tillomed portal</value>
  </data>
  <data name="Medical Conditions And Medications" xml:space="preserve">
    <value>Medical Conditions And Medications</value>
  </data>
  <data name="Medical History1" xml:space="preserve">
    <value>Medical History</value>
  </data>
  <data name="Patient Outcome1" xml:space="preserve">
    <value>Patient Outcome</value>
  </data>
  <data name="Prescriber’s Sign Off" xml:space="preserve">
    <value>Prescriber’s Sign Off</value>
  </data>
  <data name="All fields are mandatory to enable us to contact you and to verify your registration status with the GMC/GPHC/HCP Registration Number" xml:space="preserve">
    <value>All fields are mandatory to enable us to contact you and to verify your registration status with the GMC/GPHC/HCP Registration Number</value>
  </data>
  <data name="How to use Cidofovir?" xml:space="preserve">
    <value>How to use Cidofovir?</value>
  </data>
  <data name="If you prefer, you may contact the medicines and healthcare agency  (MHRA) directly. The MHRA has established a reporting service known as the yellow card scheme where healthcare professionals and patients can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit &lt;a href='https://yellowcard.mhra.gov.uk' target='_blank'&gt;https://yellowcard.mhra.gov.uk&lt;/a&gt; for further information." xml:space="preserve">
    <value>If you prefer, you may contact the medicines and healthcare agency  (MHRA) directly. The MHRA has established a reporting service known as the yellow card scheme where healthcare professionals and patients can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit &lt;a href='https://yellowcard.mhra.gov.uk' target='_blank'&gt;https://yellowcard.mhra.gov.uk&lt;/a&gt; for further information.</value>
  </data>
  <data name="Navigation" xml:space="preserve">
    <value>Navigation</value>
  </data>
  <data name="Cidofovir is an injectable antiviral medication primarily used as a treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction." xml:space="preserve">
    <value>Cidofovir is an injectable antiviral medication primarily used as a treatment of CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction.</value>
  </data>
  <data name="The Email field is requried." xml:space="preserve">
    <value>The Email field is requried.</value>
  </data>
  <data name="The Password field is required." xml:space="preserve">
    <value>The Password field is required.</value>
  </data>
  <data name="Reason for Deactivation" xml:space="preserve">
    <value>Reason for Deactivation</value>
  </data>
  <data name="Deactivate Prescriber" xml:space="preserve">
    <value>Deactivate Prescriber</value>
  </data>
  <data name="Reject Prescriber" xml:space="preserve">
    <value>Reject Prescriber</value>
  </data>
  <data name="Invalid Number" xml:space="preserve">
    <value>Invalid Number</value>
  </data>
  <data name="The '{0}' field is not a valid email address." xml:space="preserve">
    <value>The '{0}' field is not a valid email address.</value>
  </data>
  <data name="The {0} field is required." xml:space="preserve">
    <value>The {0} field is required.</value>
  </data>
  <data name="Use letters only please" xml:space="preserve">
    <value>Use letters only please</value>
  </data>
  <data name="HCP Registration Number" xml:space="preserve">
    <value>HCP Registration Number</value>
  </data>
  <data name="Other Specialisation" xml:space="preserve">
    <value>Other Specialisation</value>
  </data>
  <data name="Prescriber" xml:space="preserve">
    <value>Prescriber</value>
  </data>
  <data name="Update password" xml:space="preserve">
    <value>Update password</value>
  </data>
  <data name="The '{0}' field is required." xml:space="preserve">
    <value>The '{0}' field is required.</value>
  </data>
  <data name="Download Details" xml:space="preserve">
    <value>Download Details</value>
  </data>
  <data name="Upload Signed Form" xml:space="preserve">
    <value>Upload Signed Form</value>
  </data>
  <data name="Is the patient or patient proxy (in event the patient is unable to consent) willing to provide written informed consent?" xml:space="preserve">
    <value>Is the patient or patient proxy (in event the patient is unable to consent) willing to provide written informed consent?</value>
  </data>
  <data name="Please select the file to upload" xml:space="preserve">
    <value>Please select the file to upload</value>
  </data>
  <data name="Informed Consent Form Upload" xml:space="preserve">
    <value>Informed Consent Form Upload</value>
  </data>
  <data name="Browse" xml:space="preserve">
    <value>Browse</value>
  </data>
  <data name="Reason for Rejection" xml:space="preserve">
    <value>Reason for Rejection</value>
  </data>
  <data name="Reject Patient" xml:space="preserve">
    <value>Reject Patient</value>
  </data>
  <data name="Select File" xml:space="preserve">
    <value>Select File</value>
  </data>
  <data name="Upload" xml:space="preserve">
    <value>Upload</value>
  </data>
  <data name="The Patient is Not Approved for Cidofovir Study." xml:space="preserve">
    <value>The Patient is Not Approved for Cidofovir Study.</value>
  </data>
  <data name="Informed Consent Form is Approved Please go ahead and Approve the Baseline Data Form to Successfully Register a Patient for Cidofovir Exposure Study." xml:space="preserve">
    <value>Informed Consent Form is Approved Please go ahead and Approve the Baseline Data Form to Successfully Register a Patient for Cidofovir Exposure Study.</value>
  </data>
  <data name="(filtered from _MAX_ total entries)" xml:space="preserve">
    <value>(filtered from _MAX_ total entries)</value>
  </data>
  <data name="Abnormal parameters, if any1" xml:space="preserve">
    <value>Abnormal parameters, if any</value>
  </data>
  <data name="Adverse Events1" xml:space="preserve">
    <value>Adverse Events</value>
  </data>
  <data name="Age" xml:space="preserve">
    <value>Age</value>
  </data>
  <data name="Baseline Data" xml:space="preserve">
    <value>Baseline Data</value>
  </data>
  <data name="Baseline Data Form are Modified" xml:space="preserve">
    <value>Baseline Data Form are Modified</value>
  </data>
  <data name="Cidofovir Therapy Dates" xml:space="preserve">
    <value>Cidofovir Therapy Dates</value>
  </data>
  <data name="Details" xml:space="preserve">
    <value>Details</value>
  </data>
  <data name="DOB" xml:space="preserve">
    <value>DOB</value>
  </data>
  <data name="Dose (including units)" xml:space="preserve">
    <value>Dose (including units)</value>
  </data>
  <data name="Event Term (Diagnosis if known)" xml:space="preserve">
    <value>Event Term (Diagnosis if known)</value>
  </data>
  <data name="Female1" xml:space="preserve">
    <value>Female</value>
  </data>
  <data name="File Extension Is InValid - Only Upload PDF File" xml:space="preserve">
    <value>File Extension Is InValid - Only Upload PDF File</value>
  </data>
  <data name="File Not Selected" xml:space="preserve">
    <value>File Not Selected</value>
  </data>
  <data name="First" xml:space="preserve">
    <value>First</value>
  </data>
  <data name="Follow Up Date" xml:space="preserve">
    <value>Follow Up Date</value>
  </data>
  <data name="Gender" xml:space="preserve">
    <value>Gender</value>
  </data>
  <data name="HCP Id" xml:space="preserve">
    <value>HCP Id</value>
  </data>
  <data name="HCP Name" xml:space="preserve">
    <value>HCP Name</value>
  </data>
  <data name="Informed Consent Form and Baseline Data Form are verified" xml:space="preserve">
    <value>Informed Consent Form and Baseline Data Form are verified</value>
  </data>
  <data name="Laboratory Investigations (If Any)" xml:space="preserve">
    <value>Laboratory Investigations (If Any)</value>
  </data>
  <data name="Last" xml:space="preserve">
    <value>Last</value>
  </data>
  <data name="Loading..." xml:space="preserve">
    <value>Loading...</value>
  </data>
  <data name="Medical History (Illnesses, Conditions, Surgery)" xml:space="preserve">
    <value>Medical History (Illnesses, Conditions, Surgery)</value>
  </data>
  <data name="Medication (Record Generic or trade name)" xml:space="preserve">
    <value>Medication (Record Generic or trade name)</value>
  </data>
  <data name="Next" xml:space="preserve">
    <value>Next</value>
  </data>
  <data name="No data available in table" xml:space="preserve">
    <value>No data available in table</value>
  </data>
  <data name="No matching records found" xml:space="preserve">
    <value>No matching records found</value>
  </data>
  <data name="Patient Not Selected" xml:space="preserve">
    <value>Patient Not Selected</value>
  </data>
  <data name="Please" xml:space="preserve">
    <value>Please</value>
  </data>
  <data name="Prescribers Reference ID" xml:space="preserve">
    <value>Prescribers Reference ID</value>
  </data>
  <data name="Previous" xml:space="preserve">
    <value>Previous</value>
  </data>
  <data name="Processing..." xml:space="preserve">
    <value>Processing...</value>
  </data>
  <data name="Reason for use (Medical History diagnosis or other reason, e.g. Prophylaxis)" xml:space="preserve">
    <value>Reason for use (Medical History diagnosis or other reason, e.g. Prophylaxis)</value>
  </data>
  <data name="Route of administration (IV, Intraocular, Topical, etc.)" xml:space="preserve">
    <value>Route of administration (IV, Intraocular, Topical, etc.)</value>
  </data>
  <data name="Search" xml:space="preserve">
    <value>Search</value>
  </data>
  <data name="Server Side Validation Fail" xml:space="preserve">
    <value>Server Side Validation Fail</value>
  </data>
  <data name="Show _MENU_ entries" xml:space="preserve">
    <value>Show _MENU_ entries</value>
  </data>
  <data name="Showing 0 to 0 of 0 entries" xml:space="preserve">
    <value>Showing 0 to 0 of 0 entries</value>
  </data>
  <data name="Showing _START_ to _END_ of _TOTAL_ entries" xml:space="preserve">
    <value>Showing _START_ to _END_ of _TOTAL_ entries</value>
  </data>
  <data name="Some error occure please contact to admin." xml:space="preserve">
    <value>Some error occure please contact to admin.</value>
  </data>
  <data name="Please specify the reason" xml:space="preserve">
    <value>Please specify the reason</value>
  </data>
  <data name="Concurrent Medical Conditions And Medications" xml:space="preserve">
    <value>Concurrent Medical Conditions And Medications</value>
  </data>
  <data name="Follow Up Form Name" xml:space="preserve">
    <value>Follow Up Form Name</value>
  </data>
  <data name="Best Regards" xml:space="preserve">
    <value>Best Regards</value>
  </data>
  <data name="Dear" xml:space="preserve">
    <value>Dear</value>
  </data>
  <data name="Go To Portal" xml:space="preserve">
    <value>Go To Portal</value>
  </data>
  <data name="please contact" xml:space="preserve">
    <value>please contact</value>
  </data>
  <data name="Team" xml:space="preserve">
    <value>Team</value>
  </data>
  <data name="User Name" xml:space="preserve">
    <value>User Name</value>
  </data>
  <data name="You have any questions" xml:space="preserve">
    <value>You have any questions</value>
  </data>
  <data name="Thank you for Adding of Follow Up From" xml:space="preserve">
    <value>Thank you for Adding of Follow Up From</value>
  </data>
  <data name="Thank you for Submission of Baseline Data Form" xml:space="preserve">
    <value>Thank you for Submission of Baseline Data Form</value>
  </data>
  <data name="Thank you for Submission of Informed Consent Form" xml:space="preserve">
    <value>Thank you for Submission of Informed Consent Form</value>
  </data>
  <data name="Your Patient's" xml:space="preserve">
    <value>Your Patient's</value>
  </data>
</root>